Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Proteins Involved in Epilepsy	32/270	5.897744829485582E-11	4.187398828934763E-8	0	0	4.447192348441967	104.74857255084433	OPRD1;CHRM1;KCNC1;KCNC2;KCNA1;RASGRF1;SLC1A2;ATP1A3;AQP4;PLAT;FGF2;GRIN2A;HRH3;SV2A;TAC1;NTNG1;LGI1;GABBR2;GABRA1;KCNH3;SLC12A5;SYT1;KCNIP1;LGI4;SYN2;GABRG2;APLN;SLC6A8;PLP1;ALPL;TLN2;HCN1
Inherited Channelopathies	9/27	6.261149693536305E-8	2.2227081412053886E-5	0	0	16.08887043189369	266.85510384550196	LGI1;GABRA1;KCNA1;KCNA4;KCNAB1;GABRD;GABRG2;HCN2;HCN1
Proteins Involved in Amyotrophic Lateral Sclerosis	21/181	1.7145951146918455E-7	4.057875104770701E-5	0	0	4.277637711864407	66.64097006821564	SLC12A5;SLC1A2;CCK;FGF1;S100B;MT3;AGT;APLN;LGALS3;ADCYAP1;TRPM2;VGF;SCG5;NEFL;CSPG4;NEFM;KIF1A;TAC1;NEFH;CRYAB;PTGES
Potassium Flux Regulation	10/50	2.2442395984613487E-6	3.983525287268894E-4	0	0	8.048668885191347	104.69019361298525	OPRD1;GABBR2;HTR6;HRH1;KCNC2;ABCC8;HRH2;KCNJ9;KCNA1;KCNK3
CRH Secretion Regulation	6/24	6.671360423186254E-5	0.009473331800924481	0	0	10.672727272727272	102.61935776307706	OPRD1;GABRA1;ADCYAP1;RASGRF1;GRIK1;GRIN1
Ca2+ Flux Regulation	12/109	1.2501943488956607E-4	0.014793966461931984	0	0	3.9843725797291016	35.80772114229914	GABBR2;GRIN2A;HRH1;CHRM1;HRH3;HRH2;CAMK2A;ADRA1D;GRIN2C;ADRA2C;GRIA4;GRIN1
Vascular Motility	10/85	2.623912879562967E-4	0.026613973492710098	0	0	4.284858569051581	35.331545623181185	PPP1R14A;HTR6;HRH1;CHRM1;HRH2;RASGRF1;CAMK2A;ADRA1D;ADRA2C;MYL9
HRH1/2 -> Vascular Motility	4/13	4.94874949153373E-4	0.03942787285096112	0	0	14.190005491488193	108.00304720733037	HRH1;HRH2;CAMK2A;MYL9
Proteins Involved in Astrocytoma	10/92	4.997899375473945E-4	0.03942787285096112	0	0	3.9176575625989205	29.779379254553728	FLT1;AQP4;APOD;CSPG4;OLIG2;NPTX1;TEK;FGF1;FGF2;GFAP
Proteins Involved in Glioma	20/290	6.384712156130916E-4	0.044333871556132075	0	0	2.396315096822711	17.628333768561603	LGI1;PEG3;SLC1A2;PDGFA;AQP4;OLIG1;OLIG2;S100B;FGF2;DKK3;GFAP;ADAMTS4;LGALS3;BCAN;ADCYAP1;MAG;EFEMP1;AXL;CNTN2;CSPG4
CHRM1/2/3/5 -> Ion Channels	5/24	6.868627987569758E-4	0.044333871556132075	0	0	8.411499044641307	61.264110235274224	KCNJ4;CHRM1;KCNC1;CAMK2A;KCNK3
Muscarinic Receptor-Mediated Airway Smooth Muscle Contraction	4/15	8.998692292244062E-4	0.0532422627291107	0	0	11.608806350157256	81.41559006332777	PPP1R14A;RASGRF1;TAC1;MYL9
SOD1 Mutation	5/29	0.001692074144795606	0.09241328021576002	0	0	6.6573844884488445	42.486097646258855	CHGA;HSPB8;NEFL;CRYAB;CHGB
ADRA1 -> Vasoconstriction	4/19	0.0023188959326427426	0.11760115086973909	0	0	8.511367380560133	51.6356069097943	PPP1R14A;RASGRF1;ADRA1D;MYL9
POMC Secretion in adenohypophysis	4/20	0.0028293244299651813	0.12110040017602022	0	0	7.978995057660626	46.8184874413839	CAMK2B;PCSK2;PCSK1;CAMK2A
Exocytosis: Vesicle Priming	4/20	0.0028293244299651813	0.12110040017602022	0	0	7.978995057660626	46.8184874413839	RPH3A;RIMS1;SYT1;CACNG2
HRH1/2 -> Membrane Polarization	3/10	0.0028995870464680897	0.12110040017602022	0	0	13.662124060150376	79.83034501616987	HRH1;HRH2;KCNC2
ECL-cell: CHGA and Histamine Synthesis	4/21	0.003411585504874134	0.13069725903989934	0	0	7.509254772749298	42.656908497040895	CHGA;PCSK2;PCSK1;CCKBR
Insulin Synthesis in beta-Cell	5/34	0.00349753228416632	0.13069725903989934	0	0	5.508137020598611	31.152357442585412	PCSK2;PCSK1;PCSK1N;ABCC8;SCG5
Histamine in Arousal Regulation	3/11	0.003897003032791918	0.13135813411229416	0	0	11.95374177631579	66.31395000069021	HRH1;HRH3;HRH2
ADRA1 -> Prostaglandin Generation	4/22	0.004070252042916157	0.13135813411229416	0	0	7.091707852828116	39.03311712093363	CAMK2A;RASGRF1;ADRA1D;PTGDS
CHRM1/2/3 -> Vascular Motility	4/22	0.004070252042916157	0.13135813411229416	0	0	7.091707852828116	39.03311712093363	PPP1R14A;CHRM1;RASGRF1;MYL9
Proteins with Altered Expression in Endometrial Cancer	4/23	0.004809746669874764	0.14847478850482967	0	0	6.718113240267059	35.85531515777387	WNT10B;FLT1;PGR;FGF2
Astrocyte Dysfunction and GABA Signaling Deficiency	3/12	0.005078988428111755	0.15025340766497275	0	0	10.625	56.128083633914365	SLC32A1;SLC1A2;AQP4
beta-Cell Granules Exocytois	4/24	0.005634326101551177	0.15386044354235906	0	0	6.381878088962109	33.05096631179952	RIMS2;UNC13A;SYT1;ABCC8
G-Proteins Signaling in Insulin Secretion in beta-Cell	4/24	0.005634326101551177	0.15386044354235906	0	0	6.381878088962109	33.05096631179952	ADCYAP1;CCKBR;RASGRF1;CCK
Catecholamines Secretion from Adrenal Gland	6/54	0.00590510967459301	0.1552825136652236	0	0	3.996074380165289	20.50760299064085	CHGA;SYT1;RASGRF1;SCG2;AGT;CHGB
Histamine Effects in Inflammation	3/13	0.006454227522506127	0.16366076932069107	0	0	9.562006578947368	48.22138977738484	HRH1;HRH3;HRH2
ROS and RNS in Vasoconstriction and Vasodilation Regulation	4/26	0.0075548577291111845	0.1787982995889647	0	0	5.801108282162648	28.341688769788114	PPP1R14A;RASGRF1;MYL9;AGT
Glutamate Overdose and Aura Effect Caused by Mutations in PRRT2 Gene	4/26	0.0075548577291111845	0.1787982995889647	0	0	5.801108282162648	28.341688769788114	CAMK2A;SLC1A2;ATP1A2;CACNG2
SNS Related Adrenal Cortex Response	4/27	0.008658382194837002	0.18290050882126058	0	0	5.548599670510709	26.35156151684609	ADCYAP1;ADRA1D;ADRA2C;AGT
Glutamate Overdose and Aura Effect Caused by Mutations in SLC1A3 Gene	4/27	0.008658382194837002	0.18290050882126058	0	0	5.548599670510709	26.35156151684609	CAMK2A;SLC1A2;ATP1A2;CACNG2
Glutamate Overdose and Aura Effect Overiew	4/27	0.008658382194837002	0.18290050882126058	0	0	5.548599670510709	26.35156151684609	CAMK2A;SLC1A2;ATP1A2;CACNG2
Airway Smooth Muscle Cell Contraction	5/42	0.008758615915384309	0.18290050882126058	0	0	4.3154045134243155	20.44516699537914	PPP1R14A;HRH1;CAMK2A;RASGRF1;TAC1
GABA(B)R -> Postsynaptic Inhibition	4/28	0.009862118380932473	0.2000601157274873	0	0	5.317133443163097	24.56012802789106	ACHE;GABBR2;SLC32A1;KCNA1
Proteins Involved in Huntington Disease	8/98	0.010285203434396371	0.2028470677339284	0	0	2.844886677722499	13.021185656116165	ACHE;GRIN2A;HPCA;PPP1R1B;SLC1A2;HAP1;CPLX2;FGF2
NKX2-1 in Thyroid Dysgenesis (Hypothesis)	3/16	0.01180684961074217	0.22060166377965634	0	0	7.354251012145749	32.64607505080764	ADCYAP1;DIO2;AGT
NO Effect on Vasodilation and Vasoconstriction	3/16	0.01180684961074217	0.22060166377965634	0	0	7.354251012145749	32.64607505080764	HRH2;RASGRF1;MYL9
High Fat Diet Activates cAMP Related Exocytosis in Synapse and Endocrine Cell	4/30	0.01258305571848675	0.22304950885464359	0	0	4.907616271701939	21.472804622942416	RIMS2;UNC13A;SYT1;RASGRF1
Proteins Involved in Pulmonary Hypertension	11/165	0.012675545593387441	0.22304950885464359	0	0	2.2898809523809525	10.002384760391326	KCNC1;HLA-DPB1;PDGFA;CCK;TEK;TAC1;FGF2;SOD3;AGT;KCNK3;APLN
HTR4/6/7 -> Vasodilation	2/6	0.012880323750761109	0.22304950885464359	0	0	15.91543513957307	69.26483988826534	HTR6;MYL9
HTR1 -> Vascular Motility	3/17	0.01401662238805201	0.2261773158072029	0	0	6.82859492481203	29.141106279498022	CAMK2A;RASGRF1;MYL9
NMDA Receptors -> Ca2+/CREB Activation/PGE2 Synthesis	3/17	0.01401662238805201	0.2261773158072029	0	0	6.82859492481203	29.141106279498022	GRIN2A;GRIN2C;GRIN1
Vitamin C Related Norepinephrine Synthesis	3/17	0.01401662238805201	0.2261773158072029	0	0	6.82859492481203	29.141106279498022	ADRA1D;ADRA2C;AGT
Diabetes Induced Cataract	3/18	0.016444833920712155	0.2594629351934585	0	0	6.373026315789474	26.17875996345435	PRKCG;GJC2;CRYAB
PTGFR -> Vasoconstriction	2/7	0.017670141162513343	0.2727347875083581	0	0	12.731691297208538	51.383565590016055	PPP1R14A;MYL9
OPRD/OPRM -> Ion Channels	3/19	0.01909345340919067	0.28242399834427867	0	0	5.974403782894737	23.64913822126128	OPRD1;RGS4;KCNJ9
Glutamate Overdose and Aura Effect in Migraine Type 2	3/19	0.01909345340919067	0.28242399834427867	0	0	5.974403782894737	23.64913822126128	CAMK2A;SLC1A2;ATP1A2
Thyrotropin Releasing Hormone (TRH) Hypothalamic Release in non-Autoimmune Hypothyroidism	3/20	0.021963599994812857	0.3092927150997643	0	0	5.622678018575852	21.4694579901357	PCSK2;PCSK1;DIO2
Dopamine Mediated Glutamate Release and Glutamate Uptake Circle	3/20	0.021963599994812857	0.3092927150997643	0	0	5.622678018575852	21.4694579901357	RIMS1;SYT1;SLC1A2
CCKBR -> Neurotransmitter Uptake	2/8	0.023088047746883812	0.3092927150997643	0	0	10.60919540229885	39.980118538246266	CCKBR;CCK
Oxytocin Action in Mammary Gland	2/8	0.023088047746883812	0.3092927150997643	0	0	10.60919540229885	39.980118538246266	PPP1R14A;MYL9
TAM Receptors in Platelet Aggregation	2/8	0.023088047746883812	0.3092927150997643	0	0	10.60919540229885	39.980118538246266	AXL;TYRO3
CD157 -> cADPR/Calcium Signaling	3/21	0.025055608624912615	0.3234451295215992	0	0	5.3100328947368425	19.57627301776913	RYR1;TRPM2;RASGRF1
Glutamate Overdose and Aura Effect in Migraine Type 1	3/21	0.025055608624912615	0.3234451295215992	0	0	5.3100328947368425	19.57627301776913	CAMK2A;SLC1A2;CACNG2
Vascular Endothelial Cell Permeability Activation	4/37	0.025669852978763823	0.3254570645521842	0	0	3.865208926164445	14.156088093464716	HRH1;CAMK2A;RASGRF1;MYL9
Drugs Targets in Autistic Disoreder (Hypothesis)	3/22	0.02836909220112298	0.33314260348679076	0	0	5.030297783933518	17.920209638867387	NPAS4;ACHE;GRIN2C
Potassium Cycling in the Inner Ear (Age-Related)	3/22	0.02836909220112298	0.33314260348679076	0	0	5.030297783933518	17.920209638867387	TMIE;PCDH15;ATP1A2
Prostaglandin E2 Synthesis Activation via Glutamate in Familial Hemiplegic Migraine	2/9	0.029091325938283136	0.33314260348679076	0	0	9.093126905934788	32.165256265051106	PRKCG;CAMK2A
Adrenoceptors Physiological Effects	2/9	0.029091325938283136	0.33314260348679076	0	0	9.093126905934788	32.165256265051106	ADRA1D;ADRA2C
HRH1/3 -> Synaptic Transmission	2/9	0.029091325938283136	0.33314260348679076	0	0	9.093126905934788	32.165256265051106	HRH1;HRH3
Cold Stress and Adrenoceptor alpha 2C Signaling in Raynaud Disease	2/9	0.029091325938283136	0.33314260348679076	0	0	9.093126905934788	32.165256265051106	PPP1R14A;ADRA2C
L-cell: GCG, PYY and 5-HT Release	3/23	0.03190300023689973	0.34847892566459704	0	0	4.778536184210527	16.46232103636597	PCSK2;PCSK1;FFAR4
Telogen Maintenance in Androgenic Alopecia	3/23	0.03190300023689973	0.34847892566459704	0	0	4.778536184210527	16.46232103636597	WNT10B;PDGFA;CD34
Aqueous Humor Production	3/23	0.03190300023689973	0.34847892566459704	0	0	4.778536184210527	16.46232103636597	CA7;AQP4;ATP1A2
Proteins Involved in Neuroblastoma	12/216	0.03405943136621468	0.36600221272515354	0	0	1.8840223902582736	6.367333066416665	OPRD1;ALK;SPON1;EXTL1;FAM107A;CEND1;KIF1A;TAC1;S100B;RUNX3;FGF2;AGT
DRD1/3 -> Potassium Uptake	2/10	0.035639274610217556	0.36600221272515354	0	0	7.956075533661741	26.527998581789173	ABCC8;KCNJ9
Vasodilation Activation	2/10	0.035639274610217556	0.36600221272515354	0	0	7.956075533661741	26.527998581789173	HRH2;MYL9
Proteins Involved in Fragile X Syndrome	3/24	0.03565567413802297	0.36600221272515354	0	0	4.5507518796992485	15.171510421922674	KCNT1;AGAP2;SHANK1
Proliferative Diabetic Retinopathy	5/60	0.03608472519825458	0.36600221272515354	0	0	2.9003900390039004	9.634763985836303	FLT1;RASGRF1;PLAT;MYL9;AGT
ADRA2C/ADRB2 -> Vasoconstriction	3/25	0.039624899313332934	0.38539285633515596	0	0	4.34367523923445	14.022676296904496	RASGRF1;ADRA2C;MYL9
Proteins Involved in Sleep Disorders	3/25	0.039624899313332934	0.38539285633515596	0	0	4.34367523923445	14.022676296904496	ACHE;PTGDS;TAC1
Axonal Transport	3/25	0.039624899313332934	0.38539285633515596	0	0	4.34367523923445	14.022676296904496	KIF5A;KIF1A;HAP1
OPRL1 -> Ion Channels	2/11	0.04269312608638467	0.4041615936177749	0	0	7.071702244116037	22.30215008456845	KCNJ9;CACNG2
Glioblastoma, Proneural Subtype	2/11	0.04269312608638467	0.4041615936177749	0	0	7.071702244116037	22.30215008456845	OLIG2;NKX2-2
ADRA2C/ADRB2 -> Synaptic Endocytosis	3/26	0.04380795424570564	0.4051515464241224	0	0	4.154605263157895	12.99535546462681	SYT1;RASGRF1;ADRA2C
HIF1A as Master Regulator of Angiogenesis in Cancer	4/44	0.04472815019358971	0.4051515464241224	0	0	3.187644151565074	9.904495593598472	ARNT2;FLT1;TEK;FGF2
Ras-GRF Regulation Signaling	4/44	0.04472815019358971	0.4051515464241224	0	0	3.187644151565074	9.904495593598472	LGALS3;RASGEF1A;RASGRF1;STMN3
Myeloblast -> Neutrophil Surface Expression Markers	5/64	0.04569407636779889	0.4051515464241224	0	0	2.703194048218381	8.341479996721022	LGALS3;HRH1;FLT3;HRH2;CD34
Proteins Involved in Alzheimer's Disease	8/130	0.046170241949898196	0.4051515464241224	0	0	2.0952070249843677	6.4436411740591035	ACHE;GRIN2A;CHRM1;PLAT;GRIN2C;S100B;MT3;KLK6
Proteins Involved in Presbycusis	4/45	0.04795266849053351	0.4051515464241224	0	0	3.1097360067505124	9.445950083805217	PRKCG;PCDH15;AQP4;GRIN1
Aldosterone Synthesis Acute Regulation	3/27	0.048201656688850375	0.4051515464241224	0	0	3.9812911184210527	12.072715450057654	STAR;RASGRF1;AGT
FGFR -> RUNX2 Signaling	3/27	0.048201656688850375	0.4051515464241224	0	0	3.9812911184210527	12.072715450057654	RASGRF1;FGF1;FGF2
CNR1/2 -> Vascular Motility	2/12	0.05021596631735601	0.4051515464241224	0	0	6.364203612479475	19.038020281770244	CAMK2A;MYL9
eNOS (NOS3) Activation via Prostaglandin E2 and Histamine	2/12	0.05021596631735601	0.4051515464241224	0	0	6.364203612479475	19.038020281770244	HRH1;CAMK2A
Ghrelin Influence on Insulin Secretion (Hypothesis)	2/12	0.05021596631735601	0.4051515464241224	0	0	6.364203612479475	19.038020281770244	PTPRN2;RASGRF1
MBP/MOG/PLP in Immune System Activation	2/12	0.05021596631735601	0.4051515464241224	0	0	6.364203612479475	19.038020281770244	MOG;PLP1
nNOS (NOS1) and iNOS (NOS2) Activation via Glutamate	2/12	0.05021596631735601	0.4051515464241224	0	0	6.364203612479475	19.038020281770244	CAMK2A;GRIA4
I-cell: CCK-8 Secretion and Regulation of Eating Behavior	3/28	0.052802407114910584	0.41197482474270897	0	0	3.821842105263158	11.240796267280919	PCSK1;FFAR4;CCK
Proteins with Altered Expression in Ovarian Cancer	3/28	0.052802407114910584	0.41197482474270897	0	0	3.821842105263158	11.240796267280919	FLT1;PDGFA;LPAR3
Postsynaptic Neuron Activation	3/28	0.052802407114910584	0.41197482474270897	0	0	3.821842105263158	11.240796267280919	PRKCG;CAMK2A;GRIA4
Vascular Endothelial Cell Vasodilation in Brain	3/29	0.05760622955390546	0.43938922631010086	0	0	3.6746584008097165	10.487932810288655	CAMK2A;AGT;PTGES
Dopamine Mediated Glutamate Release/Uptake Circle in Neuron in Migraine	2/13	0.05817265813119645	0.43938922631010086	0	0	5.785341095685923	16.455476086562257	RIMS1;SYT1
FGFR1 -> STAT Signaling	2/13	0.05817265813119645	0.43938922631010086	0	0	5.785341095685923	16.455476086562257	FGF1;FGF2
Vascular Reactivity in Raynaud Disease	3/30	0.06260880998717876	0.4679184746410202	0	0	3.5383771929824563	9.804309883952255	PPP1R14A;ADRA2C;AGT
Proteins Involved in Sleep Initiation and Maintenance Disorders	2/14	0.06652976738998352	0.477132675221094	0	0	5.302955665024631	14.371570913157099	HRH1;TAC1
PTGER2/3 -> Vascular Motility	2/14	0.06652976738998352	0.477132675221094	0	0	5.302955665024631	14.371570913157099	PPP1R14A;MYL9
Glutamate Mediated Neurotoxicity	2/14	0.06652976738998352	0.477132675221094	0	0	5.302955665024631	14.371570913157099	CAMK2A;GRIA4
FGFR3 -> STAT Signaling	2/14	0.06652976738998352	0.477132675221094	0	0	5.302955665024631	14.371570913157099	FGF1;FGF2
Aldosterone Synthesis Chronic Regulation	3/31	0.06780553234419077	0.48141927964375447	0	0	3.411830357142857	9.181615873881018	STAR;AGT;KCNK3
Nociception Expression Targets Signaling	8/143	0.07233221183135717	0.5075920522000049	0	0	1.892168785701124	4.969754293327267	GRIN2A;CHRM1;HRH2;RASGRF1;TAC1;GRIN2C;HTR5A;GRIN1
A-cell (X-like): Ghrelin and Nesfatin-1 Synthesis	2/15	0.07525549200997454	0.5075920522000049	0	0	4.894783377541998	12.662150627696438	PCSK1;NKX2-2
ADORA1/2A -> Exocytosis	2/15	0.07525549200997454	0.5075920522000049	0	0	4.894783377541998	12.662150627696438	RIMS1;SYT1
Histidine-Rich Glycoprotein (HRG)	2/15	0.07525549200997454	0.5075920522000049	0	0	4.894783377541998	12.662150627696438	THBS2;FGF2
NO Synthesis in Early Vasospasm	2/15	0.07525549200997454	0.5075920522000049	0	0	4.894783377541998	12.662150627696438	HRH1;HRH2
TAM Receptor Signaling Activation in Cancer	5/74	0.0757813486383106	0.5075920522000049	0	0	2.31023102310231	5.960172124602403	FLT3;AXL;RASGRF1;TYRO3;PGR
Proteins Involved in Multiple Sclerosis	4/54	0.08251062943031251	0.5475004382759054	0	0	2.5487973640856674	6.358811418585248	MOG;PLP1;CRYAB;KLK6
Proteins Involved in Vascular Dementia	2/16	0.08431959373989317	0.5492377206910473	0	0	4.544921416842599	11.240231553564808	ACHE;KLK6
Testicular Dysgenesis Causes Male Infertility	2/16	0.08431959373989317	0.5492377206910473	0	0	4.544921416842599	11.240231553564808	STAR;PTGDS
Apoptosis and Immediate Early Gene Activation in Epileptiform Disorders	4/55	0.08694447550406326	0.5611870691625901	0	0	2.4986917336951255	6.103018520092101	GABRA1;HTR6;RASGRF1;PPP1R1B
Receptors and Adaptor Proteins Activated in Cancer	7/125	0.08879812770521173	0.5679880240603633	0	0	1.89270681333483	4.582980808682956	ALK;FLT3;AXL;PDGFA;FGF1;FGF2;NGEF
P-cell Activation	2/17	0.09369333250933629	0.5939488043002569	0	0	4.241707717569787	10.04321119164569	CCKBR;HRH2
Proteins Involved in Retinitis Pigmentosa	7/127	0.09464024020984696	0.594642217247711	0	0	1.8609685430463576	4.387554396706441	PRKCG;RIMS1;PITPNM3;CA4;PCDH15;FGF2;BEST1
PTGER1/4 -> Vascular Motility	2/18	0.10334940341885848	0.6271630463879446	0	0	3.9763957307060753	9.024985873002993	PPP1R14A;MYL9
Retinal Ganglion and Suprachiasmatic Nucleus in Melatonin Synthesis Regulation	2/18	0.10334940341885848	0.6271630463879446	0	0	3.9763957307060753	9.024985873002993	ADCYAP1;SLC32A1
Extracellular Matrix Turnover	2/18	0.10334940341885848	0.6271630463879446	0	0	3.9763957307060753	9.024985873002993	THBS2;TIMP4
Myeloid Progenitor Cell -> GEMM - CFU Surface Expression Markers	2/18	0.10334940341885848	0.6271630463879446	0	0	3.9763957307060753	9.024985873002993	FLT3;CD34
Mineralcorticoids Secretion Regulation	3/38	0.10918205231469454	0.630347889852923	0	0	2.7284774436090227	6.0428642734047076	STAR;RASGRF1;AGT
Hematopoietic Cell Lineage: B-cell	3/38	0.10918205231469454	0.630347889852923	0	0	2.7284774436090227	6.0428642734047076	FLT3;THY1;CD34
Proteins Involved in Female Infertility	4/60	0.11076990664432064	0.630347889852923	0	0	2.27500588373735	5.005695769588964	PTPRN2;YBX2;PGR;LPAR3
GCG and PPY Regulate Metabolism and Satiety	2/19	0.11326187603361151	0.630347889852923	0	0	3.742296918767507	8.150919737766621	PCSK2;PCSK1
Leukotriene Effect on Airway Smooth Muscle Response	2/19	0.11326187603361151	0.630347889852923	0	0	3.742296918767507	8.150919737766621	PPP1R14A;RASGRF1
Axonal Transport Impairment in Hungtington Disease	2/19	0.11326187603361151	0.630347889852923	0	0	3.742296918767507	8.150919737766621	KIF5A;HAP1
Cataract, Congenital	2/19	0.11326187603361151	0.630347889852923	0	0	3.742296918767507	8.150919737766621	GJC2;CRYAB
Glutamate Overdose and Aura Effect in Familial Hemiplegic Migraine Type 3	2/19	0.11326187603361151	0.630347889852923	0	0	3.742296918767507	8.150919737766621	CAMK2A;SLC1A2
Ions Reabsorption Dysregulation in Nephrolithiasis	2/19	0.11326187603361151	0.630347889852923	0	0	3.742296918767507	8.150919737766621	SLC12A1;PTH1R
Proteins Involved in Glaucoma	5/84	0.11429978560386297	0.630347889852923	0	0	2.0167523081422067	4.374195761310525	RYR1;ACHE;HSPB2;SLC1A2;AQP4
Bradykinin Effects in Inflammation	3/39	0.11573970704475035	0.630347889852923	0	0	2.6525493421052633	5.7199879427402776	PLAT;AGT;PTGES
T-lymphoid precursor cell -> CD8+ Naive T-cell Surface Expression Markers	4/61	0.11585142992617627	0.630347889852923	0	0	2.2349778895343797	4.817375683647433	FLT3;HRH2;CD34;IL12RB2
ADRA2A -> Neurotransmitter Release	1/4	0.1167213855794949	0.630347889852923	0	0	10.59344262295082	22.754349321315214	SYT1
AMPA Receptors -> Calcium Influx	1/4	0.1167213855794949	0.630347889852923	0	0	10.59344262295082	22.754349321315214	GRIA4
EDNRA/B -> Vascular Motility	3/40	0.12244129100011072	0.630347889852923	0	0	2.5807254623044096	5.419842502752525	CAMK2A;RASGRF1;MYL9
Proteins Involved in Osteoarthritis	5/86	0.12294874160754335	0.630347889852923	0	0	1.9667522307786334	4.122288573882985	ADAMTS4;WIF1;PTGDS;FGF2;PTGES
HTR5 -> TNF Production	2/20	0.12340613618247366	0.630347889852923	0	0	3.534209085933224	7.39453534599256	RASGRF1;HTR5A
Insulin Secretion	2/20	0.12340613618247366	0.630347889852923	0	0	3.534209085933224	7.39453534599256	PCSK1;ABCC8
Vascular Smooth Muscle Cell/Pericyte Differentiation and Proliferation	2/20	0.12340613618247366	0.630347889852923	0	0	3.534209085933224	7.39453534599256	TAGLN;MYH11
alpha-Cell to beta-Cell Interconversion (Hypothesis)	2/20	0.12340613618247366	0.630347889852923	0	0	3.534209085933224	7.39453534599256	PCSK2;PCSK1
Ethanol Induced Efects in Hyperprolactinemia	2/20	0.12340613618247366	0.630347889852923	0	0	3.534209085933224	7.39453534599256	RASGRF1;FGF2
Neurogenic Transcription Factors Role in Hirschsprung Disease	2/20	0.12340613618247366	0.630347889852923	0	0	3.534209085933224	7.39453534599256	ARNT2;SOX10
Smooth Muscle Cell Dysfunction in Pulmonary Hypertension	5/88	0.13189190924656302	0.6687941496829604	0	0	1.9191617956976421	3.887785306221136	PPP1R14A;TAGLN;RASGRF1;PDGFA;S100A4
Potassium Cycling in the Inner Ear (Noise-Induced)	2/21	0.13375882993659208	0.6687941496829604	0	0	3.3480252355025493	6.735278871443564	TMIE;PCDH15
G-cell: Gastrin Secretion	2/21	0.13375882993659208	0.6687941496829604	0	0	3.3480252355025493	6.735278871443564	PCSK2;CCKBR
Proteins Involved in Migraine	3/42	0.13625183884203562	0.6762464675766615	0	0	2.4481275303643724	4.879731055376191	ADCYAP1;ATP1A2;PGR
Proteins Involved in Diabetic Neuropathy	4/65	0.13715421314230883	0.6762464675766615	0	0	2.087989845248062	4.148103653920693	TRPM2;UNC13A;SLC12A5;HRH3
Proteins Involved in Dilated Cardiomyopathy	8/167	0.14012357114848475	0.686122313899477	0	0	1.6045558371663695	3.1533222219748303	SGCD;ACTC1;EYA4;LDB3;THBS2;CRYAB;AGT;APLN
Epithelial to Mesenchymal Transition in Cancer: Overview	5/90	0.1411187688666341	0.6862625061322618	0	0	1.873810910502815	3.6692092255566013	AXL;PDGFA;S100A4;FGF1;FGF2
ADORA2A/B -> Vasodilation	1/5	0.14371090528083572	0.6875935899540511	0	0	7.944672131147541	15.412279408776733	MYL9
Olanzapine Effect on Insulin Secretion in Diabetes Mellitus	1/5	0.14371090528083572	0.6875935899540511	0	0	7.944672131147541	15.412279408776733	RASGRF1
Cyclosporine Induced Nephrotoxicity	2/22	0.14429780972275155	0.6875935899540511	0	0	3.1804597701149424	6.156975712341115	SLC12A1;AGT
Proteins Involved in Hirschsprung Disease	2/23	0.15500208270357477	0.7093101134256151	0	0	3.028852920478536	5.646741158291219	ARNT2;SOX10
HRH2/4 -> IL6/10 Production	2/23	0.15500208270357477	0.7093101134256151	0	0	3.028852920478536	5.646741158291219	HRH2;RASGRF1
HTR1 -> Membrane Transport	2/23	0.15500208270357477	0.7093101134256151	0	0	3.028852920478536	5.646741158291219	RASGRF1;KCNK3
Age-Related Cataract	2/23	0.15500208270357477	0.7093101134256151	0	0	3.028852920478536	5.646741158291219	GJC2;CRYAB
Angiotensin-Aldosterone System Activation Scheme	2/23	0.15500208270357477	0.7093101134256151	0	0	3.028852920478536	5.646741158291219	STAR;AGT
BDNF Upregulation Triggered by Seizures	2/23	0.15500208270357477	0.7093101134256151	0	0	3.028852920478536	5.646741158291219	GABRA1;RASGRF1
Synaptic Exocytosis in Dementia	2/24	0.16585176106075927	0.7093101134256151	0	0	2.891028511718167	5.194197874059037	RIMS1;SYT1
Potassium Cycling in the Inner Ear (Congenital Deafness)	2/24	0.16585176106075927	0.7093101134256151	0	0	2.891028511718167	5.194197874059037	TMIE;PCDH15
Proteins Involved in Lesch-Nyhan Syndrome	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	PPP1R1B
Ion Channels of Stomach in Appetite Regulation	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	KCNK4
Renal Tubular Acidosis Associated with Carbonic Anhydrase II Mutation and Osteopetrosis	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	CA4
M-cell: Motilin Release	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	CHRM1
Prostaglandins Role in Sleep Regulation	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	PTGDS
PTGIR -> Vasodilation	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	MYL9
Renal Proximal Tubule Acid-Base Homeostasis	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	CA4
Valdecoxib Induced Ischemic Disease	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	AGT
ALK -> STAT Signaling	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	ALK
Aryl Hydrocarbon Receptor/Arachidonic Acid Metabolites Signaling	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	PTGDS
Autoimmune Polyglandular Syndromes Progression (Hypothesis)	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	PTPRN
Bone Mineralization Impairement in Osteoporosis	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	ALPL
Genes with Mutations Associated with Familial and Sporadic Hemiplegic Migraine	1/6	0.16987704158273126	0.7093101134256151	0	0	6.355409836065574	11.266110376866632	ATP1A2
AXL Receptor Tyrosine Kinase Signaling	3/47	0.17286849496108161	0.7093101134256151	0	0	2.169370514354067	3.8077314482677966	FLT3;AXL;RASGRF1
Eat me Signal: Apoptotic Cell Initiates Phagocytosis	2/25	0.17682801419201954	0.7093101134256151	0	0	2.7651888341543516	4.79090448274368	AXL;TYRO3
Leptin and CCK8 Activate Nodose Ganglia Neuron	2/25	0.17682801419201954	0.7093101134256151	0	0	2.7651888341543516	4.79090448274368	PCSK2;PCSK1
CD38 -> cADPR/Calcium Signaling	2/25	0.17682801419201954	0.7093101134256151	0	0	2.7651888341543516	4.79090448274368	RYR1;RASGRF1
Blood-Brain Barrier Disruption in Epileptiform Disorders	2/25	0.17682801419201954	0.7093101134256151	0	0	2.7651888341543516	4.79090448274368	SLC1A2;AQP4
Local Estrogen Production in Endometriosis	2/25	0.17682801419201954	0.7093101134256151	0	0	2.7651888341543516	4.79090448274368	STAR;PGR
Myeloid Cell Differentiation Block in Leukemia	2/25	0.17682801419201954	0.7093101134256151	0	0	2.7651888341543516	4.79090448274368	FLT3;MYH11
Proteins Involved in Glioblastoma	8/178	0.17907691511762708	0.7142955603006473	0	0	1.4998731831040875	2.579691690622152	ALK;AGAP2;TEK;FGF1;FGF2;CRYAB;NKX2-2;GFAP
BDKRB1/2 -> Prostaglandin Generation	2/26	0.18791302294801726	0.7375189567402766	0	0	2.6498357963875203	4.429932066141334	RASGRF1;PTGDS
Sarcomere in Cardiomyocyte in Dilated Cardiomyopathy	2/26	0.18791302294801726	0.7375189567402766	0	0	2.6498357963875203	4.429932066141334	SGCD;ACTC1
Proteins Involved in Melanoma	10/238	0.193898855442291	0.7375189567402766	0	0	1.3983273491549173	2.2938422198155886	LGALS3;FLT1;MCAM;HSPB8;TYRO3;CSPG4;MELTF;RUNX3;SOX10;FGF2
Acid Secretion by Collecting Duct of Kidney Nephron	1/7	0.19524487298797827	0.7375189567402766	0	0	5.295901639344263	8.650859296148559	CA4
GPR3 in Oocyte Meiotic Arrest	1/7	0.19524487298797827	0.7375189567402766	0	0	5.295901639344263	8.650859296148559	GPR3
Ganglioside-Type Glycosphingolipid Biosynthesis	1/7	0.19524487298797827	0.7375189567402766	0	0	5.295901639344263	8.650859296148559	ST8SIA5
Hemidesmosome Assembly	1/7	0.19524487298797827	0.7375189567402766	0	0	5.295901639344263	8.650859296148559	ITGB4
Proteins Involved in Acne Vulgaris	3/50	0.196028705048828	0.7375189567402766	0	0	2.0305851063829787	3.3088266050163226	MAL;PTH1R;TAC1
Proteins Involved in Endometrial Cancer	3/50	0.196028705048828	0.7375189567402766	0	0	2.0305851063829787	3.3088266050163226	WNT10B;FLT1;PGR
Smooth Muscle Cell Dysfunction in Arterial Hypertension	3/50	0.196028705048828	0.7375189567402766	0	0	2.0305851063829787	3.3088266050163226	TAGLN;RASGRF1;AGT
Glioma Invasion Signaling	4/75	0.19632546876607362	0.7375189567402766	0	0	1.7929786296029886	2.9189359349314214	AXL;PDGFA;TEK;FGF2
Ca2+ Toxicity in Lens Cells	2/27	0.19908993549211454	0.7412925928737336	0	0	2.5437110016420363	4.105546044304713	CAPN3;CRYAB
Proteins Involved in Hepatocellular Carcinoma	6/130	0.2073822366905809	0.7412925928737336	0	0	1.54078912290056	2.4239565585849587	FLT1;HEPACAM;FAM43B;FGF2;RUNX3;AGT
Tertiary Hypothyroidism	2/28	0.21034282506006063	0.7412925928737336	0	0	2.4457496526462044	3.8129642567027218	PCSK2;PCSK1
Central Hypothyroidism	2/28	0.21034282506006063	0.7412925928737336	0	0	2.4457496526462044	3.8129642567027218	PCSK2;PCSK1
PHOX2B Effects in Neuroblastoma	2/28	0.21034282506006063	0.7412925928737336	0	0	2.4457496526462044	3.8129642567027218	ALK;SOX10
Prolactin Production	3/52	0.21186584870264236	0.7412925928737336	0	0	1.9475026852846402	3.0221385498467948	ADCYAP1;RASGRF1;FGF2
VEGF Independent Angiogenesis in Cancer	3/52	0.21186584870264236	0.7412925928737336	0	0	1.9475026852846402	3.0221385498467948	RASGRF1;FGF1;FGF2
Proteins Involved in Neonatal Diabetes Mellitus	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	ABCC8
GABA Release	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	SLC32A1
Ghrelin and Nesfatin-1 Regulate Stomach Functional State and Satiety	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	PCSK1
Proteins with Altered Expression in Glomerulonephritis	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	AGT
Leptin -> NO Production/Vasodilation	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	MYL9
Syndromic Forms in Hirschsprung Disease	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	SOX10
Timothy Syndrome	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	CAMK2A
TACR1 -> Membrane Transport	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	TAC1
AngiopoietinR -> STAT Signaling	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	TEK
CA4 Induces Apoptosis of Choriocapillaris Endothelial Cells in RP	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	CA4
Estradiol Effects in Menstrual Migrane	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	GAD2
Leydig Cells Dysfunction in Testicular Male Infertility	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	STAR
MYOC in Cell Adhesion in Glaucoma	1/8	0.21983871571990762	0.7412925928737336	0	0	4.539110070257611	6.876121327842899	CRYAB
CHRM1 -> IL2 Production	2/29	0.22165664922192244	0.7412925928737336	0	0	2.3550446998722863	3.5481709153894	CHRM1;RASGRF1
Eat me Signal: Apoptotic Cell Induces Phagocytosis	2/29	0.22165664922192244	0.7412925928737336	0	0	2.3550446998722863	3.5481709153894	AXL;TYRO3
Vascular Smooth Muscle Cell Vasodilation in Brain	2/29	0.22165664922192244	0.7412925928737336	0	0	2.3550446998722863	3.5481709153894	RASGRF1;AGT
Airway Smooth Muscle Cell High Rate Proliferation	3/54	0.2279672230780741	0.7412925928737336	0	0	1.8709365325077398	2.766279606481101	RASGRF1;PDGFA;FGF2
FGFR -> AP-1/CREB/CREBBP/ELK/SRF/MYC Signaling	3/54	0.2279672230780741	0.7412925928737336	0	0	1.8709365325077398	2.766279606481101	RASGRF1;FGF1;FGF2
Male Sex Determination	2/30	0.2330172110066186	0.7412925928737336	0	0	2.270818672296505	3.3077720350788304	STAR;PTGDS
Sarcomere Disorganization and Intracellular Calcium Overload	2/30	0.2330172110066186	0.7412925928737336	0	0	2.270818672296505	3.3077720350788304	JPH2;ACTC1
Thyroid Hormones Common Genomic Effects in Hyperthyroidism	2/30	0.2330172110066186	0.7412925928737336	0	0	2.270818672296505	3.3077720350788304	DIO2;HR
WNT Canonical Signaling	2/30	0.2330172110066186	0.7412925928737336	0	0	2.270818672296505	3.3077720350788304	WIF1;APCDD1
Proteins Involved in Myocardial Ischemia	10/252	0.24331271957194536	0.7412925928737336	0	0	1.3164697955198637	1.860708613187584	HRH3;ABCC8;HSPB2;CDH13;PLAT;FGF1;FGF2;SOD3;AGT;APLN
Adenosine Role in Sleep Regulation	1/9	0.24368214672037233	0.7412925928737336	0	0	3.9715163934426227	5.607346585353936	SLC32A1
Proteins Involved in Pyelonephritis	1/9	0.24368214672037233	0.7412925928737336	0	0	3.9715163934426227	5.607346585353936	PLAT
AngiopoietinR -> FOXO Signaling	1/9	0.24368214672037233	0.7412925928737336	0	0	3.9715163934426227	5.607346585353936	TEK
IL12R -> STAT Signaling	1/9	0.24368214672037233	0.7412925928737336	0	0	3.9715163934426227	5.607346585353936	IL12RB2
Genes with Mutations Associated with Usher Syndrome and Retinitis Pigmentosa	1/9	0.24368214672037233	0.7412925928737336	0	0	3.9715163934426227	5.607346585353936	PCDH15
HIF1A in Pathologic Ocular Neovascularization	1/9	0.24368214672037233	0.7412925928737336	0	0	3.9715163934426227	5.607346585353936	FLT1
IL10/STAT3 Signaling in M2 Macrophage and Retinal Angiogenesis	1/9	0.24368214672037233	0.7412925928737336	0	0	3.9715163934426227	5.607346585353936	FGF2
MELAS Syndrome	1/9	0.24368214672037233	0.7412925928737336	0	0	3.9715163934426227	5.607346585353936	ABCC8
Proteins Involved in Prolactinoma	2/31	0.2444111212796778	0.7412925928737336	0	0	2.192401336277674	3.0888820219843725	PDGFA;FGF2
Vascular Endothelial Cell Activation by NO	2/31	0.2444111212796778	0.7412925928737336	0	0	2.192401336277674	3.0888820219843725	PLAT;AGT
Vitamine D Deficite and Dentin Formation	2/31	0.2444111212796778	0.7412925928737336	0	0	2.192401336277674	3.0888820219843725	ALPL;PTH1R
AngiopoietinR -> AP-1 Signaling	2/31	0.2444111212796778	0.7412925928737336	0	0	2.192401336277674	3.0888820219843725	RASGRF1;TEK
Proteins Involved in High-Grade Serous Ovarian Carcinoma	3/57	0.25251868180578996	0.7412925928737336	0	0	1.7667214912280702	2.4314858673903386	FLT1;LPAR3;FGF2
Angiogenesis in Endometriosis	3/57	0.25251868180578996	0.7412925928737336	0	0	1.7667214912280702	2.4314858673903386	FLT1;RASGRF1;TEK
ROS in Triggering Vascular Inflammation	2/32	0.25582576287580727	0.7412925928737336	0	0	2.1192118226600987	2.8890339119823056	RASGRF1;AGT
Glutamate Toxiicity Effects on Striatum Medium Spiny Neurons in Hantington's Disease	2/32	0.25582576287580727	0.7412925928737336	0	0	2.1192118226600987	2.8890339119823056	CHRM1;SLC1A2
Proteins Involved in Endometriosis	10/256	0.25820570410562244	0.7412925928737336	0	0	1.2947932307942047	1.753148362920567	LGALS3;TAGLN;FLT1;STAR;SNCG;PGR;FGF1;RUNX3;FGF2;PTGES
Glutamate Release	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	SLC1A2
Histamine Receptor H3 Signaling in Neurons	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	HRH3
HTR2 -> Membrane Transport	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	KCNA1
HTR4/6/7 -> Cation Channels	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	HTR6
Proteins Mutated in Cochlear Hair Cell Synapse	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	PCDH15
Retinoic Acid Signaling Inhibition in Pre-Puberty Block of Meiosis	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	ALDH1A3
AGER -> NF-kB Signaling	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	S100B
IL12R -> NF-kB/NFATC Signaling	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	IL12RB2
VEGFR -> FOXO3A Signaling	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	FLT1
WNT/Calcium non-Canonical Signaling	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	CAMK2A
MGAM Inhibitors	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	SLC2A5
Netrin-1 Signaling in Age-Related Macular Degeneration	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	FLT1
Nitroxyl and CGRP in Migraine Pain Activation	1/10	0.2667980260620489	0.7412925928737336	0	0	3.530054644808743	4.664131873466129	MYL9
Thyroid Stimulating Hormone (TSH) Resistance in Congenital Hypothyroidism	2/33	0.26724925598197424	0.7412925928737336	0	0	2.0507442131468827	2.706107745726628	ADCY2;PDE8B
Alcoholic Dilated Cardiomyopathy (Mouse Model)	2/33	0.26724925598197424	0.7412925928737336	0	0	2.0507442131468827	2.706107745726628	SGCD;ACTC1
Proteins Involved in Psoriatic Arthritis	3/59	0.26909129242114604	0.7412925928737336	0	0	1.7034480733082706	2.2361240874968202	FGF1;FGF2;RUNX3
Proteins Involved in Periodontitis	3/61	0.2857811981832624	0.7412925928737336	0	0	1.64453833938294	2.059831636519341	FGF2;EDIL3;TIMP4
Proteins Involved in Diabetic Nephropathy	7/175	0.2879272882661192	0.7412925928737336	0	0	1.325951986754967	1.6508729437181682	BGN;PLP1;PTGDS;FGF2;SOD3;CNDP1;AGT
Hypertrophic Cardiomyopathy	4/89	0.2889426261026113	0.7412925928737336	0	0	1.496579125884291	1.8580435962184394	JPH2;ACTC1;RASGRF1;AGT
ADRB1 -> Prostaglandin Generation	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	PTGDS
ADRB1/3 -> Vasodilation	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	MYL9
Agomelatine Antidepressant Action	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	SLC32A1
Fatty Acids Block TLR Signaling in Enteroendocrine Cell	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	FFAR4
Proteins Involved in Oligodendroglioma	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	LGALS3
Proteins Involved in Raynaud Disease	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	ADRA2C
Proteins Involved in Usher Syndromes	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	PCDH15
Proteins Mutated in Cochlear Hair Cell Stereocilia	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	PCDH15
Proteins Mutated in Photoreceptor and Retinal Pigment Epithelial Cell	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	PCDH15
SERPINA1 Associated Pulmonary Emphysema	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	FGF2
Adherens Junctions Dysfunction in Cardiomyocyte	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	CTNNA3
Alstrom Syndrome Progression (Hypothesis)	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	HAP1
Androgen Receptor/SGK1 Signaling	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	SLC2A5
Angelman Syndrome: Effects of Mutation of Maternal Copy of UBE3A Gene	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	ARC
beta-Casomorphins/Opioid Receptors Affect Brain Function (Hypothesis)	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	GFAP
Ca2+ Reabsorption Decline in Intestine	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	PTH1R
Ca2+ Reabsorption Dysregulation in Urolithiasis	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	PTH1R
Dioxin Role in Endometriosis	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	SNCG
Dopamine Action in CSD Progression	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	CAMK2A
GABRB3 Mutation and Adenosine Deaminase Polymorphism	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	SLC32A1
Hexosamine Pathway in Diabetic Microangiopathy	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	PLAT
Metals and Amyloid beta Toxicity in Alzheimer's Disease	1/11	0.2892085186282031	0.7412925928737336	0	0	3.1768852459016395	3.9412671330986053	HSPB8
VEGFA Dependent Angiogenesis in Cancer	3/62	0.2941582199716221	0.7512673963304018	0	0	1.6165811775200714	1.978109339667564	BGN;PGR;FGF2
Norepinephrine Release Regulation	2/36	0.3014644202594079	0.7590061644829065	0	0	1.8695064232589587	2.2417312819953055	SYT1;CACNG2
WNT Signaling Activation by Blocking of Tumor Suppressors	2/36	0.3014644202594079	0.7590061644829065	0	0	1.8695064232589587	2.2417312819953055	WIF1;CTNNA3
JNK/MAPK Signaling	2/36	0.3014644202594079	0.7590061644829065	0	0	1.8695064232589587	2.2417312819953055	MAPK8IP2;MAPK8IP1
Lysophosphatidic Acid/LPARs Signaling	2/36	0.3014644202594079	0.7590061644829065	0	0	1.8695064232589587	2.2417312819953055	RASGRF1;LPAR3
CNR1/2 -> Membrane Transport	1/12	0.3109351150719592	0.7606194412213301	0	0	2.8879284649776453	3.3735943457575166	KCNK3
Endocannabinoids Role in Sleep Regulation	1/12	0.3109351150719592	0.7606194412213301	0	0	2.8879284649776453	3.3735943457575166	DAGLA
EPHB -> NMDA Receptor Activation	1/12	0.3109351150719592	0.7606194412213301	0	0	2.8879284649776453	3.3735943457575166	CAMK2A
Prostaglandin E2 and Histamine in Gastric Acid Secretion	1/12	0.3109351150719592	0.7606194412213301	0	0	2.8879284649776453	3.3735943457575166	HRH2
TACR1 -> TNF/IL6/IL8 Production	1/12	0.3109351150719592	0.7606194412213301	0	0	2.8879284649776453	3.3735943457575166	TAC1
beta-Cell Death in Diabetes Mellitus Type 2	1/12	0.3109351150719592	0.7606194412213301	0	0	2.8879284649776453	3.3735943457575166	ABCC8
IL23R -> STAT3/NF-kB Signaling	1/12	0.3109351150719592	0.7606194412213301	0	0	2.8879284649776453	3.3735943457575166	IL12RB2
Th1-Cell Activation in Crohn's Disease	2/37	0.3128181363896174	0.7606194412213301	0	0	1.815998123387286	2.110431875957039	RUNX3;IL12RB2
Contraction Due Vasospasm	2/37	0.3128181363896174	0.7606194412213301	0	0	1.815998123387286	2.110431875957039	PPP1R14A;RASGRF1
VEGFR -> ATF/CREB/ELK-SRF Signaling	2/37	0.3128181363896174	0.7606194412213301	0	0	1.815998123387286	2.110431875957039	FLT1;RASGRF1
Proteins Involved in Hypertrophic Cardiomyopathy	3/65	0.319363277238121	0.7608016510382929	0	0	1.538120755517827	1.7556510584314702	ACTC1;FGF2;AGT
VEGFA/NOTCH1/WNT Cross-talk in Blood Vessel Sprouting and Branching in Cancer	2/38	0.3241312510534379	0.7608016510382929	0	0	1.7654625068418173	1.9889819759765561	FLT1;NRARP
EDN, NRG, NRTN, and GDNF/RET Signaling in Hirschsprung Disease	2/38	0.3241312510534379	0.7608016510382929	0	0	1.7654625068418173	1.9889819759765561	RASGRF1;GFRA2
Progesterone Resistance in Endometriosis	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	PGR
Estrogens Procoagulant Effect	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	PLAT
K-cell: GIP Production	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	FFAR4
Retinoic Acid Role in Endometriosis	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	PGR
Sodium Flux Regulation	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	HRH3
Steroid Hormones Steroidogenesis	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	STAR
VEGFA Low Expression Level in Chronic Bronchitis	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	FLT1
VEGFR -> CTNNB Signaling	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	FLT1
Hyperhomocysteinemia Induced Thrombophilia	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	PLAT
MTHFR Mutation, Hyperhomocysteinemia and Folate Deficiency	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	PLAT
Osteoblast Dysfunction in Hypoparathyroidism	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	PTH1R
Phelan-McDermid Syndrome	1/13	0.331998652444818	0.7608016510382929	0	0	2.6471311475409838	2.918791311151541	SHANK1
DRD2 Expression Targets	2/39	0.3353956574295573	0.7608016510382929	0	0	1.7176585452447521	1.876446419554554	RASGRF1;TAC1
TRPM4/6/7/8 Signaling in Arterial Hypertension (Hypothesis)	2/39	0.3353956574295573	0.7608016510382929	0	0	1.7176585452447521	1.876446419554554	TAGLN;RASGRF1
VEGFA in Neovascular Glaucoma	2/39	0.3353956574295573	0.7608016510382929	0	0	1.7176585452447521	1.876446419554554	FLT1;RASGRF1
Inhibition of THBS1 Activates Angiogenesis in Cancer	2/39	0.3353956574295573	0.7608016510382929	0	0	1.7176585452447521	1.876446419554554	THBS2;FGF2
Aryl Hydrocarbon Receptor Genomic and non-Genomic Signaling	2/39	0.3353956574295573	0.7608016510382929	0	0	1.7176585452447521	1.876446419554554	RASGRF1;AHRR
Hair Follicle Keratinocyte Apoptosis	2/39	0.3353956574295573	0.7608016510382929	0	0	1.7176585452447521	1.876446419554554	WNT10B;PTGDS
Proteins Involved in Diabetes Mellitus Type 1	4/97	0.34437242441644067	0.7634643420312307	0	0	1.3672742732635383	1.4575575512383114	PTPRN2;HLA-DPB1;GAD2;AGT
Proteins Involved in Azoospermia	2/40	0.34660378025492494	0.7634643420312307	0	0	1.67237058162648	1.7719987060595848	YBX2;CDH18
Dendritic Spine Morphogenesis and Stabilization	2/40	0.34660378025492494	0.7634643420312307	0	0	1.67237058162648	1.7719987060595848	PTPRT;SHANK1
Proteins Involved in Parkinson's Disease	4/98	0.35134013174171685	0.7634643420312307	0	0	1.3526586981667776	1.4148816589583748	SNCG;TAC1;SNCB;KLK6
Estrogens in Prolactin Production	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	FGF2
GRM2-4/6-8 (Presynaptic) -> Glutamate Release Attenuation	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	RIMS1
Hormones Underlie Human Gastrointestinal Functions and Eating Behavior	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	CCK
P2RXs -> Synaptic Transmission	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	SLC32A1
EphrinR -> Actin Signaling	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	NGEF
Ca2+/Pi Reabsorption Decline in Kidney in Hyperparathyroidism	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	PTH1R
Ca2+/Pi Reabsorption Decline in Kidney in Hypoparathyroidism	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	PTH1R
Crystallin alpha B (CRYAB) Suppresses Multiple Sclerosis	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	CRYAB
Hodgkin and Reed-Sternberg Cells in Hodgkin Lymphoma	1/14	0.3524193339778382	0.7634643420312307	0	0	2.443379571248424	2.548282463527549	FGF2
Proteins with Altered Expression in Endometriosis	2/41	0.3577485511079259	0.7634643420312307	0	0	1.6294050776809397	1.6749060687518849	STAR;PGR
Steroidogenesis Impairement in Polycystic Ovary Syndrome	2/41	0.3577485511079259	0.7634643420312307	0	0	1.6294050776809397	1.6749060687518849	STAR;RASGRF1
Transcytosis	2/41	0.3577485511079259	0.7634643420312307	0	0	1.6294050776809397	1.6749060687518849	CHRM1;CAVIN2
Megakaryocyte -> Platelet Precursor Cell Surface Expression Markers	2/41	0.3577485511079259	0.7634643420312307	0	0	1.6294050776809397	1.6749060687518849	FLT3;CD34
Dilated Cardiomyopathy	3/70	0.3613673874672624	0.7634643420312307	0	0	1.422967399842891	1.44838180298581	PPP1R14A;SGCD;ACTC1
Proteins Involved in Osteoporosis	4/100	0.3652757455336837	0.7634643420312307	0	0	1.3243410214168039	1.3337474758736885	PTH1R;TAC1;FGF2;AGT
Serotonin Receptors Signaling	2/42	0.3688233844564079	0.7634643420312307	0	0	1.5885878489326766	1.5845169058032744	HTR6;RASGRF1
HIF1A in Vasculogenic Mimicry of Cancer	2/42	0.3688233844564079	0.7634643420312307	0	0	1.5885878489326766	1.5845169058032744	LGALS3;FLT1
Proteins Involved in Rett Syndrome	1/15	0.3722167482503664	0.7634643420312307	0	0	2.268735362997658	2.2421433746935917	NTNG1
PTPRN/STAT5 in Insulin Synthesis in beta-Cell (Rodent Model)	1/15	0.3722167482503664	0.7634643420312307	0	0	2.268735362997658	2.2421433746935917	PTPRN
N-cell: Neurotensin Production	1/15	0.3722167482503664	0.7634643420312307	0	0	2.268735362997658	2.2421433746935917	FFAR4
ADAM33 Role in Asthma	1/15	0.3722167482503664	0.7634643420312307	0	0	2.268735362997658	2.2421433746935917	TIMP4
Androgens Synthesis in Sebocytes	1/15	0.3722167482503664	0.7634643420312307	0	0	2.268735362997658	2.2421433746935917	STAR
Complement Component GPCRs Signaling	1/15	0.3722167482503664	0.7634643420312307	0	0	2.268735362997658	2.2421433746935917	RASGRF1
Glutamate Mediated Excitotoxicity in Amyotrophic Lateral Sclerosis	1/15	0.3722167482503664	0.7634643420312307	0	0	2.268735362997658	2.2421433746935917	SLC1A2
GNRH Release Impairment in Hypogonadotrophic Hypogonadism	1/15	0.3722167482503664	0.7634643420312307	0	0	2.268735362997658	2.2421433746935917	PCSK1
Glioma Stem Cell Program Activation	3/72	0.3780779239670006	0.7634643420312307	0	0	1.381578947368421	1.3437996110192865	PEG3;PDGFA;OLIG2
Proteins Involved in Mucinous Ovarian Carcinoma	2/43	0.3798221549707995	0.7634643420312307	0	0	1.549761704513597	1.5002501485679505	FGF1;FGF2
T-Cell Cytotoxic Activation	2/43	0.3798221549707995	0.7634643420312307	0	0	1.549761704513597	1.5002501485679505	BGN;S100B
WNT in Epithelial to Mesenchymal Transition in Cancer	2/43	0.3798221549707995	0.7634643420312307	0	0	1.549761704513597	1.5002501485679505	AXL;S100A4
VEGFR -> AP-1/CREB/MYC Signaling	2/43	0.3798221549707995	0.7634643420312307	0	0	1.549761704513597	1.5002501485679505	FLT1;RASGRF1
Graves Ophthalmopathy	2/43	0.3798221549707995	0.7634643420312307	0	0	1.549761704513597	1.5002501485679505	HAS1;THY1
IgE Induces Airway Smooth Muscle Cell Proliferation	2/43	0.3798221549707995	0.7634643420312307	0	0	1.549761704513597	1.5002501485679505	RASGRF1;MYL9
Proteins Involved in Erectile Dysfunction	2/44	0.3907391754805581	0.7634643420312307	0	0	1.5127844241144734	1.421586233213881	FGF2;AGT
MC1R in anti-Inflammatory Signaling	2/44	0.3907391754805581	0.7634643420312307	0	0	1.5127844241144734	1.421586233213881	PCSK2;PCSK1
Norepinephrine Neuronal Release	2/44	0.3907391754805581	0.7634643420312307	0	0	1.5127844241144734	1.421586233213881	SYT1;CACNG2
T-Cells Differentiation Block in Psoriasis	2/44	0.3907391754805581	0.7634643420312307	0	0	1.5127844241144734	1.421586233213881	RUNX3;IL12RB2
Eosinophil Activation and Degranulation in Asthma	2/44	0.3907391754805581	0.7634643420312307	0	0	1.5127844241144734	1.421586233213881	TAC1;MYL9
Proteins Involved in Androgenetic Alopecia	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	HR
GRM1/5 (Postsynaptic) -> Ion Channels	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	KCNJ9
Vitamin K Metabolism	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	MGP
Exocytosis: Vesicle Fusion	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	SYT1
Aminoglycosides and Cisplatin Induced Ototoxicity (Mouse Model)	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	HRK
DRD2 Pharmacological Inhibition in Hyperprolactinemia	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	RASGRF1
Extraocular Muscles Weakness in Myasthenia Gravis	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	MYL9
Hypothyrodism Associated Hyperprolactinemia	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	RASGRF1
Neurofibrillary Tangle Formation	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	GRIN2A
Penile Detumescense Augmentation Mechanisms	1/16	0.39140988802727883	0.7634643420312307	0	0	2.1173770491803277	1.986099589789913	PPP1R14A
Hemapoietic Stem Cell -> Lymphoid Multipotent Progenitor Surface Expression Markers	2/45	0.4015691761199163	0.7641462472535389	0	0	1.4775270172222859	1.3480594012199472	FLT3;CD34
Proteins with Altered Expression in Cancer Metastases	4/106	0.40692931134724775	0.7641462472535389	0	0	1.2460509739315826	1.120344106825455	LGALS3;AXL;S100A4;FGF2
ADRA1 -> Ion Channels	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	ADRA1D
Aldosterone Renal Effects	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	SLC12A1
D-cell: Somatostatin Release	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	CCKBR
P2RY1/2/4/6 -> Potassium Channels	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	KCNJ4
PTGIR -> IL6 Production	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	RASGRF1
Vascularization in Hepatocellular Carcinoma	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	PDGFA
Aldosterone Signaling in Arterial Hypertension	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	SLC12A1
AGER -> CREB/SP1 Signaling	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	S100B
Cochlear Hair Cell Stereocilia Proteins Mutations (Age-Related)	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	PCDH15
PTPRC -> BCL6 Signaling	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	RASGRF1
SELE -> ELK-SRF Signaling	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	RASGRF1
Oxytocin Signaling in Brain Nerve Cell (Hypothesis)	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	GFAP
PGF2-alpha Effect on Treatment	1/17	0.410017168034572	0.7641462472535389	0	0	1.9849385245901638	1.7696843413215289	RASGRF1
Proteins Involved in Atherosclerosis	7/200	0.4116857950099658	0.7641462472535389	0	0	1.1526953299248532	1.0230111736031622	LPAR3;PLAT;PTGDS;FGF1;FGF2;AGT;APLN
Proteins with Altered Expression in Melanoma	2/46	0.41230728417506446	0.7641462472535389	0	0	1.4438722197342888	1.2792511099595965	FLT1;FGF1
MERTK Signaling	2/46	0.41230728417506446	0.7641462472535389	0	0	1.4438722197342888	1.2792511099595965	LGALS3;RASGRF1
IL1B Expression Targets -> Nociception	2/47	0.4229490047271148	0.7641462472535389	0	0	1.4117131910235359	1.2147843725515264	TAC1;FGF2
Proteins Involved in Antiphospholipid Syndrome	1/18	0.4280564430086509	0.7641462472535389	0	0	1.8680810028929604	1.5850671342860754	PLAT
Proteins Involved in Cryptorchidism	1/18	0.4280564430086509	0.7641462472535389	0	0	1.8680810028929604	1.5850671342860754	PTGDS
CR3 Mediated Phagocytosis in Neutrophils and Macrophages	1/18	0.4280564430086509	0.7641462472535389	0	0	1.8680810028929604	1.5850671342860754	RASGRF1
Proteins Involved in Hutchinson-Gilford Progeria Sindrome	1/18	0.4280564430086509	0.7641462472535389	0	0	1.8680810028929604	1.5850671342860754	PRELP
Wolfram Syndrome Progression (Hypothesis)	1/18	0.4280564430086509	0.7641462472535389	0	0	1.8680810028929604	1.5850671342860754	ABCC8
Alternative Lengthening of Telomeres in Cancer	1/18	0.4280564430086509	0.7641462472535389	0	0	1.8680810028929604	1.5850671342860754	TCEAL7
CFL1 in Cancer Cell Motility	1/18	0.4280564430086509	0.7641462472535389	0	0	1.8680810028929604	1.5850671342860754	RASGRF1
FOXL2 Mutation in Ovarian Dysgenesis	1/18	0.4280564430086509	0.7641462472535389	0	0	1.8680810028929604	1.5850671342860754	STAR
Proteins Involved in Endometrioid Ovarian Carcinoma	2/48	0.4334902023867324	0.7641462472535389	0	0	1.380952380952381	1.154318878182277	LPAR3;FGF2
Vascular Smooth Muscle Cell/Pericyte Migration and Proliferation	2/48	0.4334902023867324	0.7641462472535389	0	0	1.380952380952381	1.154318878182277	MYH11;FGF2
Glioblastoma, Primary	2/48	0.4334902023867324	0.7641462472535389	0	0	1.380952380952381	1.154318878182277	PDGFA;FGF2
Proplatelet Maturation	3/79	0.43566714630409986	0.7641462472535389	0	0	1.2538737880886426	1.0418145818431441	ADCYAP1;RASGRF1;MYL9
CDH2 Activation Promotes Cancer Cell Migration and Survival	2/49	0.44392708325805136	0.7641462472535389	0	0	1.3515005415225518	1.0975467740625564	PDGFA;FGF2
Hematopoietic Cell Lineage: B-cell (mouse)	2/49	0.44392708325805136	0.7641462472535389	0	0	1.3515005415225518	1.0975467740625564	FLT3;CD34
Proerythroblast -> Erythrocyte Surface Expression Markers	2/49	0.44392708325805136	0.7641462472535389	0	0	1.3515005415225518	1.0975467740625564	ACHE;CD34
Cardiomyocyte Dysfunction	2/49	0.44392708325805136	0.7641462472535389	0	0	1.3515005415225518	1.0975467740625564	SGCD;ACTC1
PPARGC1A Repression in Huntington Disease	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	MOBP
Proteins Involved in HPV Infection	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	PGR
DRD1/5 Expression Targets	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	TAC1
Proteins with Altered Expression in Amyotrophic Lateral Sclerosis	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	SLC1A2
Luteinizing Hormone in Oocyte Meiotic Resumption	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	RASGRF1
Renin-Angiotensin-Aldosterone System in Myocardial ischemia	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	AGT
T-Cell Genetic Rearrangements in Acute Lymphoblastic Leukemia	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	OLIG2
ANGPT/TEK Stimulates Endothelial Cell Migration in Cancer	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	TEK
FBLN5 Potentiates Migration and Proliferation of Endothelial Cells in Cancer	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	TEK
Exocytosis: Vesicle Docking	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	RPH3A
Hedgehog Signaling Activation by Blocking of Tumor Suppressors	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	NKX2-2
Hedgehog Signaling Activation in Cancer	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	NKX2-2
Genes with Mutations Associated with Ichthyosis	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	NIPAL4
Neonatal Diabetes Mellitus	1/19	0.445545024116038	0.7641462472535389	0	0	1.764207650273224	1.4262859765852216	ABCC8
Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling	6/175	0.44572944023184885	0.7641462472535389	0	0	1.1278791138931	0.9113749889548142	ALK;AXL;TYRO3;PDGFA;FGF1;FGF2
Glioblastoma, Secondary	2/50	0.4542561784160397	0.7641462472535389	0	0	1.3232758620689655	1.0441890039903055	PDGFA;FGF2
Plasmin Role in Glomerulonephritis	2/50	0.4542561784160397	0.7641462472535389	0	0	1.3232758620689655	1.0441890039903055	RASGRF1;PLAT
Proteins Involved in Hearing Loss	7/209	0.4565245999986731	0.7641462472535389	0	0	1.100821257622451	0.8631679198589675	TMIE;GJB1;KCNC1;KCNA1;EYA4;PCDH15;AQP4
Acute Myeloid Leukemia	3/82	0.4597519745871717	0.7641462472535389	0	0	1.2060709526982012	0.9371992885137083	ALK;FLT3;MYH11
Growth Factor Signaling in Hepatocellular Carcinoma	3/82	0.4597519745871717	0.7641462472535389	0	0	1.2060709526982012	0.9371992885137083	FLT1;PDGFA;RUNX3
Proteins Involved in Hyperprolactinemia	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	TAC1
Proteins Involved in Vasospasm	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	PLAT
Proteins with Altered Expression in Polycystic Ovary Syndrome	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	STAR
OPRK -> Pain Perception	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	RASGRF1
P2RY11/13/14 -> IL8/10 Production	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	RASGRF1
Gap Junction Assembly	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	GJB1
Amyloid beta and APP Intracellular Transport in Alzheimer Disease	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	SPON1
Goblet-Cell Exocytosis in Asthma	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	SYT2
Oxygen Shortage in Myocardial Ischemia	1/20	0.46249969595561774	0.7641462472535389	0	0	1.6712683347713546	1.2887306884750709	ACTC1
ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy	2/51	0.46447432720176823	0.7641462472535389	0	0	1.2962032103481786	0.9939921252882228	RASGRF1;AGT
Myocardial Remodeling	2/51	0.46447432720176823	0.7641462472535389	0	0	1.2962032103481786	0.9939921252882228	RASGRF1;AGT
Dopamine Synthesis and Release	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	CCKBR
GALR1/2/3 -> POMC/NPY Production	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	RASGRF1
RET1 Mutation in Hyperparathyroidism	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	RASGRF1
Sonic Hedgehog Signaling in Neuroblastoma	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	NKX2-2
B-Cell Receptor -> AP-1 Signaling	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	RASGRF1
CCL2 Role in CGRP Expression and Release	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	SYT1
KIT -> MITF Signaling	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	RASGRF1
NOTCH -> TCF3 Signaling	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	MAPK8IP1
Dopamine Synthesis and Release in Migraine	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	CCKBR
EGFR and PTAFR Signaling in Ovarian Cancer	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	RASGRF1
VEGFR -> NFATC Signaling	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	RASGRF1
FSH Action in Polycystic Ovary Syndrome	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	RASGRF1
Genes with Mutations Associated with Cataract	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	CRYAB
Glutamate Mediated Excitotoxicity in Glaucoma	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	SLC1A2
IL1B Induced Arthralgia	1/21	0.47893673243355606	0.7641462472535389	0	0	1.5876229508196722	1.1687870167412682	PTGES
LH and FSH Signaling and Steroidogenesis	1/22	0.4948719119051991	0.7725534719361451	0	0	1.511943793911007	1.0635864078262405	STAR
Proteins with Altered Expression in Rheumatoid Arthritis	1/22	0.4948719119051991	0.7725534719361451	0	0	1.511943793911007	1.0635864078262405	FGF2
Advanced Glycation End Products Pathway in Diabetic Microangiopathy	1/22	0.4948719119051991	0.7725534719361451	0	0	1.511943793911007	1.0635864078262405	PLAT
CD19 -> JUN/ELK Signaling	1/22	0.4948719119051991	0.7725534719361451	0	0	1.511943793911007	1.0635864078262405	RASGRF1
Epithelial Cell in the Innate Immune Response in Ulcerative Colitis	1/22	0.4948719119051991	0.7725534719361451	0	0	1.511943793911007	1.0635864078262405	ECM1
LH and FSH Signaling Impairment in Primary Ovarian Insufficiency	1/22	0.4948719119051991	0.7725534719361451	0	0	1.511943793911007	1.0635864078262405	STAR
Myocarditis, Acute Viral Overiew	1/22	0.4948719119051991	0.7725534719361451	0	0	1.511943793911007	1.0635864078262405	SGCD
OPTN Associated Glaucoma	1/22	0.4948719119051991	0.7725534719361451	0	0	1.511943793911007	1.0635864078262405	CNTN2
Proteins Involved in Glomerulonephritis	4/121	0.507811649492984	0.7725534719361451	0	0	1.0854560047311284	0.7355534748989438	AXL;PLAT;THBS2;AGT
Coagulation Cascade	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	PLAT
NPY1R -> CRH/POMC Production	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	RASGRF1
Thrombophilia Hereditary	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	PLAT
Transcription Factors in beta-Cell Neogenesis (Rodent Model)	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	NKX2-2
Scavenger Receptors in Platelet Activation	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	MATK
Somatostatin Receptors Signaling	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	SSTR3
Werner Syndrome (Adult Progeria)	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	BRINP1
ActivinR -> SMAD2/3 Signaling	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	GDF1
EGFR -> SMAD1 Signaling	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	RASGRF1
beta-Catenin/Androgen Receptor Signaling in Prostate Cancer	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	CTNNA3
Bone Resorption in Hyperparathyroidism	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	PTH1R
ICAM1 -> AP-1/CREB/ELK/SRF Signaling	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	RASGRF1
UrokinaseR -> ELK/SRF Signaling	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	RASGRF1
Hereditary Thrombophilia and Pregnancy Complications	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	PLAT
Hodgkin and Reed-Sternberg Cells Reprogramming	1/23	0.5103205328704958	0.7725534719361451	0	0	1.4431445603576751	0.9708268038654689	MSC
Proteins Involved in Arterial Hypertension	8/255	0.519858700020018	0.7802535018836755	0	0	1.028165515204007	0.6726240653989812	TAGLN;RAMP3;FLT1;SLC12A1;BGN;SOD3;AGT;APLN
Prolactinoma Overiew	2/57	0.52331144070469	0.7802535018836755	0	0	1.154440961337513	0.7475911498118294	RASGRF1;FGF2
Genes with Mutations Associated with Retinitis Pigmentosa	2/57	0.52331144070469	0.7802535018836755	0	0	1.154440961337513	0.7475911498118294	CA4;BEST1
Proteins Involved in Congenital Deafness	1/24	0.525297428028728	0.7802535018836755	0	0	1.380327868852459	0.8886421720771384	PCDH15
Proteins Involved in Graves Disease	1/24	0.525297428028728	0.7802535018836755	0	0	1.380327868852459	0.8886421720771384	HLA-DPB1
Proteins Involved in Hypoxia-Induced Pulmonary Hypertension	1/24	0.525297428028728	0.7802535018836755	0	0	1.380327868852459	0.8886421720771384	TEK
WNT Signaling in Melanoma	1/24	0.525297428028728	0.7802535018836755	0	0	1.380327868852459	0.8886421720771384	CAMK2A
ALK Associated Neuroblastoma	1/24	0.525297428028728	0.7802535018836755	0	0	1.380327868852459	0.8886421720771384	ALK
Amyloid beta Traffic and Degradation in Extracellular Matrix in Alzheimer's Disease	1/24	0.525297428028728	0.7802535018836755	0	0	1.380327868852459	0.8886421720771384	LGI3
Proteins Involved in Chronic Bronchitis	1/25	0.5398169787194865	0.7933499793562023	0	0	1.3227459016393444	0.8155060825766195	TAC1
AGTR1 -> ARRB1/ARRB2 Signaling	1/25	0.5398169787194865	0.7933499793562023	0	0	1.3227459016393444	0.8155060825766195	AGT
beta-Cell Recovery in Diabetes Mellitus	1/25	0.5398169787194865	0.7933499793562023	0	0	1.3227459016393444	0.8155060825766195	ABCC8
Sialophorin -> CTNNB/MYC/TP53 Signaling	1/25	0.5398169787194865	0.7933499793562023	0	0	1.3227459016393444	0.8155060825766195	LGALS3
Proteins Involved in Male Infertility	6/193	0.5404672789405122	0.7933499793562023	0	0	1.0183585981349714	0.6266176165444465	UGT8;STAR;SPAG6;CHD5;YBX2;AGT
Steroids Induced Cataract	2/59	0.5419362535038847	0.7933499793562023	0	0	1.1138190303344568	0.6823332210185272	FGF2;CRYAB
Bone Remodeling in Hyperthyroidism	2/59	0.5419362535038847	0.7933499793562023	0	0	1.1138190303344568	0.6823332210185272	ALPL;PTH1R
Proteins Involved in Spontaneous Abortion	3/93	0.5438242693427792	0.794475784430809	0	0	1.0580592105263158	0.6444946743444244	FLT1;HLA-DPB1;PGR
Proteins Involved in Multiple Myeloma	2/60	0.5510573603507443	0.7993173195076302	0	0	1.0945586320140421	0.6522654100010599	HAS1;CD34
Proteins Involved in Cataract	3/94	0.5510877955251073	0.7993173195076302	0	0	1.046377964141122	0.6234959707707656	CAPN3;FGF2;CRYAB
Respiratory Chain Impairment in Cancer	1/26	0.5538931284475409	0.7993173195076302	0	0	1.2697704918032786	0.7501594804649355	COX7A1
Endothelial Cell Dysfunction in Progressive Diabetic Nephropathy	1/26	0.5538931284475409	0.7993173195076302	0	0	1.2697704918032786	0.7501594804649355	FLT1
Nitric Oxide Effects on beta-Cell	1/26	0.5538931284475409	0.7993173195076302	0	0	1.2697704918032786	0.7501594804649355	ABCC8
OPTN Effects on NF-kB Signaling in Glaucoma	1/26	0.5538931284475409	0.7993173195076302	0	0	1.2697704918032786	0.7501594804649355	CNTN2
Proteins Involved in Ichthyosis	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	NIPAL4
IL6 Expression Targets -> Nociception	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	MYL9
NTSR1 Expression Targets	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	RASGRF1
Cancer Cells Inhibit Adipocyte Differentiation	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	WNT10B
ActivinR/BMPR -> SMAD1/5/9 Signaling	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	GDF1
FcIgER -> ELK-SRF Signaling	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	RASGRF1
Ca2+ Toxicity in Neurons	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	CHRM1
Endothelin Signaling in Arterial Hypertension	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	RASGRF1
MIF Role in Cholesteatoma	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	LGALS3
Osteoblast Function Decline in Gout	1/27	0.5675393964082219	0.8022294007221891	0	0	1.2208701134930644	0.6915559070182001	PTH1R
Treg-Cell Function in Diabetes Mellitus Type 1	2/62	0.568912812944511	0.8022294007221891	0	0	1.0579638752052545	0.5967213387057887	PTPRN;GAD2
Neuroblastoma	4/131	0.5706015342656375	0.8022294007221891	0	0	0.9994681472064756	0.5607657478063963	ALK;CHD5;SOX10;NKX2-2
Proteins Involved in Hypothyroidism	2/63	0.5776459975430702	0.8022294007221891	0	0	1.0405663678699293	0.5710566406185015	DIO2;SSTR3
TLR2 Signaling in Treg-Cell in Type 1 Diabetes (Animal Model)	2/63	0.5776459975430702	0.8022294007221891	0	0	1.0405663678699293	0.5710566406185015	PTPRN;GAD2
Proteins Involved in Hypogonadotropic Hypogonadism	1/28	0.580768890100289	0.8022294007221891	0	0	1.175591985428051	0.6388194837110865	PCSK1
Proteins with Altered Expression in Breast Cancer	1/28	0.580768890100289	0.8022294007221891	0	0	1.175591985428051	0.6388194837110865	FLT1
EZH2 Methyltransferase Role in Cancer	1/28	0.580768890100289	0.8022294007221891	0	0	1.175591985428051	0.6388194837110865	RUNX3
EGFR -> NCOR2 Signaling	1/28	0.580768890100289	0.8022294007221891	0	0	1.175591985428051	0.6388194837110865	RASGRF1
ERBB2/3 -> EP300/ETS/ETV/SP1 Signaling	1/28	0.580768890100289	0.8022294007221891	0	0	1.175591985428051	0.6388194837110865	RASGRF1
CFTR Related Ion-Channel Dysfunction in Cystic Fibrosis Airway Epithelium (Class III Mutations)	1/28	0.580768890100289	0.8022294007221891	0	0	1.175591985428051	0.6388194837110865	AQP4
Il17 Signaling Related Neutrophilia in Asthma	1/28	0.580768890100289	0.8022294007221891	0	0	1.175591985428051	0.6388194837110865	IL12RB2
MYOC Associated Glaucoma	1/28	0.580768890100289	0.8022294007221891	0	0	1.175591985428051	0.6388194837110865	WIF1
Cetuximab Resistance in Colorectal Cancer	2/64	0.5862489713102293	0.8068064684864357	0	0	1.0237300704486467	0.5466828257794958	FLT1;AXL
Proteins Involved in Polycystic Ovary Syndrome	3/99	0.5863551235760575	0.8068064684864357	0	0	0.9916221217105263	0.5293573001093519	PGR;AGT;APLN
HTR1 -> IL6 Production	1/29	0.5935943182047997	0.8089124218295338	0	0	1.1335480093676815	0.5912123463750649	RASGRF1
RARA Signaling in Acute Myeloid Leukemia (M3)	1/29	0.5935943182047997	0.8089124218295338	0	0	1.1335480093676815	0.5912123463750649	FLT3
Apoptosis of Melanocyte in Vitiligo	1/29	0.5935943182047997	0.8089124218295338	0	0	1.1335480093676815	0.5912123463750649	RASGRF1
GDNF -> HSF1 Signaling	1/29	0.5935943182047997	0.8089124218295338	0	0	1.1335480093676815	0.5912123463750649	RASGRF1
FLT3/KIT/MLL Signaling in Leukemia	1/29	0.5935943182047997	0.8089124218295338	0	0	1.1335480093676815	0.5912123463750649	FLT3
Cardiomyocyte Hypertrophy	2/65	0.5947215270352347	0.8089124218295338	0	0	1.0074282586597858	0.5235221885695975	RASGRF1;AGT
Toll-like Receptor Independent Sterile Inflammation	2/66	0.6030635915141249	0.8149240181918582	0	0	0.9916358784893268	0.5015026200882907	BGN;S100B
ADRA1A -> IL6 Production	1/30	0.6060280022609875	0.8149240181918582	0	0	1.0944036178631995	0.5481091632434203	RASGRF1
Thrombopoietin Receptors Signaling in Platelet Maturation	1/30	0.6060280022609875	0.8149240181918582	0	0	1.0944036178631995	0.5481091632434203	RASGRF1
Vitamin A (Retinol) Metabolism and Visual Cycle	1/30	0.6060280022609875	0.8149240181918582	0	0	1.0944036178631995	0.5481091632434203	ALDH1A3
Androgens Promote Scalp Dermal Papilla Regression	1/30	0.6060280022609875	0.8149240181918582	0	0	1.0944036178631995	0.5481091632434203	WNT10B
Mast-Cell Related Chemokines Signaling in Asthma	1/30	0.6060280022609875	0.8149240181918582	0	0	1.0944036178631995	0.5481091632434203	RASGRF1
Skin Fibrosis	2/67	0.611275217504578	0.820416360123689	0	0	0.976329417708728	0.4805571338370394	PDGFA;AGT
Proteins Involved in Otitis Media	1/31	0.6180818888404234	0.820416360123689	0	0	1.0578688524590163	0.5089770153019787	CA4
Leukocyte Adhesion to Endothelial Cell	1/31	0.6180818888404234	0.820416360123689	0	0	1.0578688524590163	0.5089770153019787	CD34
Th17-Cell Numbers Reduction in HIV	1/31	0.6180818888404234	0.820416360123689	0	0	1.0578688524590163	0.5089770153019787	IL12RB2
CD38/CD3 -> JUN/FOS/NF-kB Signaling in T-cell Proliferation	1/31	0.6180818888404234	0.820416360123689	0	0	1.0578688524590163	0.5089770153019787	RASGRF1
GNRH Signaling Impairment in Hypogonadotrophic Hypogonadism	1/31	0.6180818888404234	0.820416360123689	0	0	1.0578688524590163	0.5089770153019787	RASGRF1
Proteins Involved in Medulloblastoma	2/68	0.6193565760933765	0.820416360123689	0	0	0.961486789072996	0.46062343765962155	ADCYAP1;FGF2
Plasmin Effects in Inflammation	2/68	0.6193565760933765	0.820416360123689	0	0	0.961486789072996	0.46062343765962155	RASGRF1;PLAT
Sertoli Cells Dysfunction Causes Male Infertility	1/32	0.629767560747561	0.8234529799829987	0	0	1.0236911686938128	0.47335938138383116	RASGRF1
Endosomal Recycling	1/32	0.629767560747561	0.8234529799829987	0	0	1.0236911686938128	0.47335938138383116	EPN3
Apoptosis Block in Acute Myeloid Leukemia Cell	1/32	0.629767560747561	0.8234529799829987	0	0	1.0236911686938128	0.47335938138383116	FLT3
EGFR/ERBB2 -> HIF1A Signaling	1/32	0.629767560747561	0.8234529799829987	0	0	1.0236911686938128	0.47335938138383116	RASGRF1
Coagulation Factors and PAR1/2 Receptors (F2R/F2RL1) in Endometriosis	1/32	0.629767560747561	0.8234529799829987	0	0	1.0236911686938128	0.47335938138383116	RASGRF1
non-Hereditary Genetic Rearrangements in Neuroblastoma	1/32	0.629767560747561	0.8234529799829987	0	0	1.0236911686938128	0.47335938138383116	CHD5
Ovulation Block	1/32	0.629767560747561	0.8234529799829987	0	0	1.0236911686938128	0.47335938138383116	RASGRF1
Proteins Involved in Obesity	3/106	0.632653687136763	0.8241910419579848	0	0	0.923894992335207	0.422988788475288	CCK;TAC1;AGT
Endometrial Cancer	3/106	0.632653687136763	0.8241910419579848	0	0	0.923894992335207	0.422988788475288	FLT1;PGR;FGF2
Hypothalamic-Pituitary-Adrenal Axis in Acute Phase Response	1/33	0.641096248044221	0.8291044373613787	0	0	0.9916495901639344	0.440863291243885	PCSK1
Autocrine Cytokine/Chemokine Loops in Systemic Scleroderma	1/33	0.641096248044221	0.8291044373613787	0	0	0.9916495901639344	0.440863291243885	PDGFA
Dentin Formation Disruption	1/33	0.641096248044221	0.8291044373613787	0	0	0.9916495901639344	0.440863291243885	RASGRF1
Overt Hypothyroidism, Primary	1/33	0.641096248044221	0.8291044373613787	0	0	0.9916495901639344	0.440863291243885	ADCY2
Alveolar Macrophages Dysfunction in COPD	2/72	0.65038650540064	0.8341909470505204	0	0	0.9063570255688482	0.38990434130360707	BGN;S100B
Melanoma	4/145	0.6504353800631594	0.8341909470505204	0	0	0.8995758701671983	0.3869195684606964	FLT1;MCAM;FGF1;SOX10
Proteins Involved in Acute Myeloid Leukemia	1/34	0.652078838891604	0.8341909470505204	0	0	0.9615499254843517	0.41114894592422135	FLT3
Proteins Involved in Breast Cancer Related to WNT Signaling Pathway	1/34	0.652078838891604	0.8341909470505204	0	0	0.9615499254843517	0.41114894592422135	WNT10B
Leukotriene Effect on Vascular Endothelial Cell Response	1/34	0.652078838891604	0.8341909470505204	0	0	0.9615499254843517	0.41114894592422135	RASGRF1
mTOR Signaling Activation by Taste Sensor Receptors (Rodent Model)	1/34	0.652078838891604	0.8341909470505204	0	0	0.9615499254843517	0.41114894592422135	RASGRF1
Hodgkin Lymphoma	3/110	0.6574439589316259	0.8383575819000991	0	0	0.8891724053123463	0.37291512969643065	RASGRF1;MSC;FGF2
GFs/TNF -> Ion Channels	1/35	0.6627258899129834	0.8383575819000991	0	0	0.9332208293153327	0.3839212756519851	CAMK2A
Thyroid Stimulating Hormone (TSH) Secretion in Overt Hypothyroidism	1/35	0.6627258899129834	0.8383575819000991	0	0	0.9332208293153327	0.3839212756519851	CCK
V(D)J Recombination Activation	1/35	0.6627258899129834	0.8383575819000991	0	0	0.9332208293153327	0.3839212756519851	FLT3
KRAS Signaling	1/35	0.6627258899129834	0.8383575819000991	0	0	0.9332208293153327	0.3839212756519851	RASAL1
Huntingtin Gene Mutation in Striatal Neuron	1/35	0.6627258899129834	0.8383575819000991	0	0	0.9332208293153327	0.3839212756519851	SLC1A2
Proteins Involved in Age-Related Macular Degeneration	4/148	0.6661958348575405	0.8383575819000991	0	0	0.8806974190005491	0.3577142844874262	EFEMP1;FLT1;CRYAB;BEST1
Hepatocellular Carcinoma	3/112	0.6693791368014931	0.8383575819000991	0	0	0.8727667793336552	0.3503326503135161	FLT1;PDGFA;RUNX3
Dopamine Receptors Signaling	1/36	0.673047636173319	0.8383575819000991	0	0	0.9065105386416862	0.358923030274886	RASGRF1
Thyroid Dysfunction	1/36	0.673047636173319	0.8383575819000991	0	0	0.9065105386416862	0.358923030274886	ADCY2
ANGPT/TEK Maintains Endothelial Cell Quiescence in Cancer	1/36	0.673047636173319	0.8383575819000991	0	0	0.9065105386416862	0.358923030274886	TEK
Tumor Infiltrating Macrophages in Cancer Progression and Immune Escape	1/36	0.673047636173319	0.8383575819000991	0	0	0.9065105386416862	0.358923030274886	FGF2
Cochlear Hair Cell Stereocilia Proteins Mutations (Congenital Deafness)	1/36	0.673047636173319	0.8383575819000991	0	0	0.9065105386416862	0.358923030274886	PCDH15
Estrogen Effects on Pregnancy Gingivitis	1/36	0.673047636173319	0.8383575819000991	0	0	0.9065105386416862	0.358923030274886	PGR
Hyperparathyroidism, Secondary Effect	1/36	0.673047636173319	0.8383575819000991	0	0	0.9065105386416862	0.358923030274886	PTH1R
Mast-Cell Activation in Asthma	2/76	0.6793719681877034	0.8447532353997714	0	0	0.8571872364975813	0.33137699968653644	HAS1;TAC1
Intraflagellar Transport: Anterograde Transport	1/37	0.6830540009464807	0.8448925795679466	0	0	0.8812841530054645	0.3359290903969937	KIF17
ERK5/MAPK7 Signaling	1/37	0.6830540009464807	0.8448925795679466	0	0	0.8812841530054645	0.3359290903969937	PTPRR
PDGFR -> AP-1/MYC Signaling	1/37	0.6830540009464807	0.8448925795679466	0	0	0.8812841530054645	0.3359290903969937	RASGRF1
Proteins Involved in Diabetes Mellitus Type 2	3/115	0.6867064819462843	0.8479332211858466	0	0	0.8492569313909775	0.31919179441965806	ABCC8;CCK;AGT
Proteins Involved in Pulmonary Emphysema	1/38	0.6927546056122212	0.8494918307161954	0	0	0.8574213557820115	0.31474175709017366	SOD3
HGFR -> AP-1/CREB/MYC Signaling	1/38	0.6927546056122212	0.8494918307161954	0	0	0.8574213557820115	0.31474175709017366	RASGRF1
Dedifferentiation and Metastatic Progression in Melanoma	1/38	0.6927546056122212	0.8494918307161954	0	0	0.8574213557820115	0.31474175709017366	MCAM
Genes with Mutations Associated with Testicular Male Infertility	1/38	0.6927546056122212	0.8494918307161954	0	0	0.8574213557820115	0.31474175709017366	STAR
CNR1/2 -> IL1B/2/4/6/10 Production	1/39	0.7021587781124461	0.8549845257313247	0	0	0.8348144952545298	0.2951868332537102	RASGRF1
Proteins Involved in Stem Cell Exhaustion in Aging	1/39	0.7021587781124461	0.8549845257313247	0	0	0.8348144952545298	0.2951868332537102	FGF2
CD38/CD19 -> JUN/FOS/NF-kB Signaling in B-cell Proliferation	1/39	0.7021587781124461	0.8549845257313247	0	0	0.8348144952545298	0.2951868332537102	RASGRF1
Podocyte Dysfunction in Diabetic Nephropathy	1/39	0.7021587781124461	0.8549845257313247	0	0	0.8348144952545298	0.2951868332537102	AGT
TGFB Family in Epithelial to Mesenchymal Transition in Cancer	2/80	0.7063667088875245	0.8549845257313247	0	0	0.8130605027156751	0.2826367087838828	TAGLN;AXL
Proteins Involved in Noise-Induced Hearing Loss	1/40	0.7112755625323276	0.8549845257313247	0	0	0.8133669609079445	0.27711034459379386	PCDH15
Apoptosis Block by BCL2 Family Proteins in Cancer	1/40	0.7112755625323276	0.8549845257313247	0	0	0.8133669609079445	0.27711034459379386	HRK
G0/G1 Phase Transition	1/40	0.7112755625323276	0.8549845257313247	0	0	0.8133669609079445	0.27711034459379386	RASGRF1
High-Grade Serous Ovarian Carcinoma	2/82	0.719138661468006	0.8549845257313247	0	0	0.7926518883415435	0.26133818890628324	FLT1;LPAR3
AXL Receptor Inhibits Macrophages and Dendritic Cells Function	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	AXL
Circadian Clock Genes in Suprachiasmatic Nuclei Neurons	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	ADCYAP1
Proteins Involved in Thrombophilia	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	PLAT
Th17-Cell Activation in Crohn's Disease	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	IL12RB2
Golgi to Endosome Transport	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	SMOC2
AMPK Signaling	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	RASGRF1
Astrocytoma	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	PDGFA
EGFR/ERBB2 -> TP53 Signaling	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	RASGRF1
Club-Cell Role in Asthma	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	LGALS3
Mesangial Cell Dysfunction in Glomerulonephritis	1/41	0.7201137273061016	0.8549845257313247	0	0	0.7929918032786886	0.2603757856473378	AGT
Sebocyte Proliferation in Acne Vulgaris	1/42	0.7286817738924908	0.8594087366506121	0	0	0.7736105557776889	0.244861794646301	RXRG
Clozapine Induced Granulocytopenia	1/42	0.7286817738924908	0.8594087366506121	0	0	0.7736105557776889	0.244861794646301	RASGRF1
Skeletal Muscle Wasting in Cancer Cachexia	1/42	0.7286817738924908	0.8594087366506121	0	0	0.7736105557776889	0.244861794646301	FBXO40
EGFR -> AP-1/ATF2 Signaling	1/42	0.7286817738924908	0.8594087366506121	0	0	0.7736105557776889	0.244861794646301	RASGRF1
Proteins Involved in Atopic Dermatitis	1/43	0.7369879446822228	0.8677635832908428	0	0	0.755152224824356	0.23046018342030444	TAC1
Mast-Cell Activation via IgE Signaling	2/86	0.7432803709126097	0.8729019207537516	0	0	0.754750175932442	0.22392075820608318	HAS1;TAC1
Translation	1/44	0.745040230953202	0.8729019207537516	0	0	0.7375524208921083	0.21707426068897095	EEF1A2
HRAS Signaling	1/44	0.745040230953202	0.8729019207537516	0	0	0.7375524208921083	0.21707426068897095	RASGRF1
Adipokines Production by Adipocyte	1/46	0.7604139052866524	0.8836233596620675	0	0	0.7046994535519125	0.19301181173708742	APLN
Proteins Involved in Clear Cell Ovarian Carcinoma	1/46	0.7604139052866524	0.8836233596620675	0	0	0.7046994535519125	0.19301181173708742	PDGFA
Toll-like Receptors in beta-Cell	1/46	0.7604139052866524	0.8836233596620675	0	0	0.7046994535519125	0.19301181173708742	IL12RB2
Ras-GAP Regulation Signaling	1/46	0.7604139052866524	0.8836233596620675	0	0	0.7046994535519125	0.19301181173708742	RASAL1
Peripheral Tissue Microangiopathy	1/46	0.7604139052866524	0.8836233596620675	0	0	0.7046994535519125	0.19301181173708742	PLAT
Proteins Involved in Myocarditis	5/207	0.761694399124584	0.8836650708798279	0	0	0.783705845832108	0.21333245446504517	HRH1;MOG;CA4;THBS2;AGT
Ovarian Cancer	3/130	0.763171032569515	0.8839338223888347	0	0	0.7483682138416908	0.20226380817006195	FLT1;PDGFA;LPAR3
BSG (CD147) in Cancer Cells Motility, Invasion and Survival	1/47	0.7677500878851788	0.8849067571403847	0	0	0.6893442622950819	0.18218748800401066	LGALS3
Genes with Mutations in Cancer-Associated Evading of Growth Suppressors	1/47	0.7677500878851788	0.8849067571403847	0	0	0.6893442622950819	0.18218748800401066	CTNNA3
FibronectinR -> AP-1/ELK/SRF/SREBF Signaling	1/47	0.7677500878851788	0.8849067571403847	0	0	0.6893442622950819	0.18218748800401066	RASGRF1
Proteins Involved in Low-Grade Serous Ovarian Carcinoma	1/48	0.7748619895025034	0.8852425575742672	0	0	0.674642483432159	0.17208129002101993	FGF2
Bone Loss in Osteoporosis	1/48	0.7748619895025034	0.8852425575742672	0	0	0.674642483432159	0.17208129002101993	PTH1R
Endometrioid Endometrial Cancer	2/92	0.776148632973325	0.8852425575742672	0	0	0.7042145593869732	0.17845588458164174	PGR;FGF2
ESR1/ERBB Positive Luminal Breast Cancer	2/93	0.7812546552606706	0.8852425575742672	0	0	0.6964398491492088	0.1719190455483876	FLT1;PGR
Proteins Involved in Systemic Scleroderma	1/49	0.7817564557733317	0.8852425575742672	0	0	0.6605532786885245	0.16263616008463547	PDGFA
mTOR Signaling Activation by Fatty Acids and Glucose	1/49	0.7817564557733317	0.8852425575742672	0	0	0.6605532786885245	0.16263616008463547	ABCC8
Platelet Activation via GPCR Signaling	1/49	0.7817564557733317	0.8852425575742672	0	0	0.6605532786885245	0.16263616008463547	RASGRF1
Skin Aging	1/49	0.7817564557733317	0.8852425575742672	0	0	0.6605532786885245	0.16263616008463547	RASGRF1
EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling	1/49	0.7817564557733317	0.8852425575742672	0	0	0.6605532786885245	0.16263616008463547	RASGRF1
Mesangial Cell Dysfunction in Diabetic Nephropathy	1/49	0.7817564557733317	0.8852425575742672	0	0	0.6605532786885245	0.16263616008463547	AGT
Polycystins Mutation Effects in Cystic Kidney Disease	1/49	0.7817564557733317	0.8852425575742672	0	0	0.6605532786885245	0.16263616008463547	RASGRF1
Proteins Involved in Pancreatic Cancer	2/94	0.7862582749817038	0.8885595048060551	0	0	0.6888341543513957	0.16564391217802224	FLT1;FGF2
Proteins Involved in Hodgkin Lymphoma	1/50	0.7884401239828376	0.8885595048060551	0	0	0.647039143526263	0.15380043578066482	HLA-DPB1
Th17-Cell Function in Systemic Lupus Erythematosus	1/50	0.7884401239828376	0.8885595048060551	0	0	0.647039143526263	0.15380043578066482	IL12RB2
Scavenger Receptor OLR1 in Inflammation Related Endothelial Dysfunction	1/51	0.7949194289700612	0.8888075505019581	0	0	0.6340655737704918	0.14552725370181363	AGT
Vascular Endothelial Cell Activation by Growth Factors	1/51	0.7949194289700612	0.8888075505019581	0	0	0.6340655737704918	0.14552725370181363	PTGES
Airway Epithelial Cell Dysfunction	1/51	0.7949194289700612	0.8888075505019581	0	0	0.6340655737704918	0.14552725370181363	AQP4
NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling	1/51	0.7949194289700612	0.8888075505019581	0	0	0.6340655737704918	0.14552725370181363	RASGRF1
ESR1 Signaling in Breast Cancer	1/51	0.7949194289700612	0.8888075505019581	0	0	0.6340655737704918	0.14552725370181363	PGR
Proteins Involved in Polycystic Kidney Disease	2/97	0.8006695335485441	0.8916182330187088	0	0	0.6669777893008383	0.14827382100006758	LGALS3;AGT
EGFR Signaling	1/52	0.8012006093886426	0.8916182330187088	0	0	0.6216007714561235	0.13777402830133692	RASGRF1
Polycystic Ovary Syndrome	1/52	0.8012006093886426	0.8916182330187088	0	0	0.6216007714561235	0.13777402830133692	STAR
HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes	1/53	0.8072897140210512	0.8955870264921036	0	0	0.6096153846153847	0.13050199541841606	RASGRF1
Muscular Dystrophies	1/53	0.8072897140210512	0.8955870264921036	0	0	0.6096153846153847	0.13050199541841606	AGT
Proteins Involved in Ulcerative Colitis	3/141	0.8090517438912291	0.8961415571962132	0	0	0.6883223684210527	0.14585028113663193	TAC1;FGF2;CD34
G0/G1 Cell Cycle Phase Transition Activation in Cancer	1/54	0.8131926070739216	0.8979265179198823	0	0	0.5980822765233529	0.12367581221602	RASGRF1
ERBB/VEGFR/Akt Signaling in Breast Cancer	1/54	0.8131926070739216	0.8979265179198823	0	0	0.5980822765233529	0.12367581221602	FLT1
Th1-Cell Function in Systemic Lupus Erythematosus	1/55	0.8189149740680083	0.9014412892841641	0	0	0.586976320582878	0.1172632045904357	IL12RB2
Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease	1/55	0.8189149740680083	0.9014412892841641	0	0	0.586976320582878	0.1172632045904357	PDGFA
Hyaluronic Acid, CD44 and HMMR in Cancer Cell Invasion and Survival	1/56	0.8244623271513363	0.9050482448203754	0	0	0.576274217585693	0.11123465648033055	HAS1
Neutrophil Activation via Adherence on Endothelial Cells	1/57	0.8298400103916399	0.9050482448203754	0	0	0.5659543325526932	0.10556313512040015	CD34
Synovial Fibroblast Proliferation in Rheumatoid Arthritis	1/57	0.8298400103916399	0.9050482448203754	0	0	0.5659543325526932	0.10556313512040015	FGF2
Vascular Endothelial Cell Activation by Blood Coagulation Factors	1/57	0.8298400103916399	0.9050482448203754	0	0	0.5659543325526932	0.10556313512040015	RASGRF1
CFTR Facilitates Oxidative Stress in Airway Epithelium in CF	1/57	0.8298400103916399	0.9050482448203754	0	0	0.5659543325526932	0.10556313512040015	AGT
MITF as a Regulator of Melanoma Cell Development	1/57	0.8298400103916399	0.9050482448203754	0	0	0.5659543325526932	0.10556313512040015	SOX10
Proteins with Altered Expression in Cancer-Associated Evading of Growth Suppressors	1/58	0.8350532051384396	0.9079445262607844	0	0	0.5559965487489215	0.10022384749054686	WIF1
VEGF Signaling	1/58	0.8350532051384396	0.9079445262607844	0	0	0.5559965487489215	0.10022384749054686	FLT1
Proteins Involved in Psoriasis	1/59	0.8401069345378871	0.9120426965166665	0	0	0.5463821368004522	0.09519402455673924	S100A4
Toll-like Receptors in Sterile Inflammation	1/60	0.8450060686567009	0.9159607767118437	0	0	0.5370936371214227	0.0904527288524135	BGN
Proteins Involved in Diffuse Large-B-Cell Lymphoma	1/61	0.8497553291630717	0.9193768525795019	0	0	0.5281147540983606	0.08598068316979635	ALK
CD8+ T-Cell Activation	1/62	0.8543592936705733	0.9193768525795019	0	0	0.5194302606826122	0.08176011770818735	IL12RB2
Neutrophil Degranulation via FPR1 Signaling	1/62	0.8543592936705733	0.9193768525795019	0	0	0.5194302606826122	0.08176011770818735	SYT1
Th17-Cell Differentiation	1/63	0.8588224001845138	0.9193768525795019	0	0	0.5110259122157589	0.07777463319160649	IL12RB2
EGFR Transactivation in Cancer and Non-Cancer Cells	1/63	0.8588224001845138	0.9193768525795019	0	0	0.5110259122157589	0.07777463319160649	LPAR3
Dendritic Cell Dysfunction in Psoriatic Arthritis	1/63	0.8588224001845138	0.9193768525795019	0	0	0.5110259122157589	0.07777463319160649	CNTN2
Genes with Mutations in Cancer-Associated Sustaining of Proliferative Signaling	2/112	0.860501633280211	0.9193768525795019	0	0	0.5755784445439618	0.08647477040438609	ALK;FLT3
anti-Inflammatory Function of Macrophage M2 Lineage	1/64	0.8631489514192778	0.9193768525795019	0	0	0.5028883684621389	0.07400907820114695	RASGRF1
Th1-Cell Differentiation	1/64	0.8631489514192778	0.9193768525795019	0	0	0.5028883684621389	0.07400907820114695	IL12RB2
Neutrophil Degranulation via FPR1/IL8	1/64	0.8631489514192778	0.9193768525795019	0	0	0.5028883684621389	0.07400907820114695	CD34
Th17-Cell Differentiation in Asthma	1/65	0.8673431187381124	0.9193768525795019	0	0	0.49500512295081966	0.07044943920341114	IL12RB2
Androgens in Sebocyte Maturation	1/65	0.8673431187381124	0.9193768525795019	0	0	0.49500512295081966	0.07044943920341114	PTGDS
B-Cell Activation in Systemic Lupus Erythematosus	1/65	0.8673431187381124	0.9193768525795019	0	0	0.49500512295081966	0.07044943920341114	RASGRF1
Proteins Involved in Inflammatory Bowel Diseases	1/66	0.8714089464538682	0.9193768525795019	0	0	0.4873644388398487	0.06708274139721959	TAC1
Th17-Cell and Th1 Immune Responsein Psoriatic Arthritis	1/66	0.8714089464538682	0.9193768525795019	0	0	0.4873644388398487	0.06708274139721959	IL12RB2
Vascular Endothelial Cell Activation by Cytokines	1/66	0.8714089464538682	0.9193768525795019	0	0	0.4873644388398487	0.06708274139721959	PTGES
Alzheimer's Disease	1/67	0.875350355413723	0.9193768525795019	0	0	0.4799552906110283	0.06389695974907662	CHRM1
CD16/CD14 Proinflammatory Monocyte Activation	1/67	0.875350355413723	0.9193768525795019	0	0	0.4799552906110283	0.06389695974907662	RASGRF1
STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis	1/67	0.875350355413723	0.9193768525795019	0	0	0.4799552906110283	0.06389695974907662	FGF2
Alveolar Epithelial Cell Dysfunction in COPD	1/67	0.875350355413723	0.9193768525795019	0	0	0.4799552906110283	0.06389695974907662	S100B
Endothelial Cell Dysfunction in Pulmonary Hypertension	1/67	0.875350355413723	0.9193768525795019	0	0	0.4799552906110283	0.06389695974907662	TEK
Proteins Involved in Primary Ovarian Insufficiency	1/68	0.8791711469121476	0.9220258704691652	0	0	0.47276731098605335	0.06088093850896288	CPEB1
Cholesteatoma	1/70	0.8864655065228443	0.9269374221372894	0	0	0.45901639344262296	0.055317471980070365	LGALS3
Growth Factor Signaling in Pancreatic Neoplasms	1/70	0.8864655065228443	0.9269374221372894	0	0	0.45901639344262296	0.055317471980070365	FLT1
Cytokines Trigger Otitis Media	1/71	0.8899461114197597	0.9286344469213369	0	0	0.45243559718969556	0.052751442087789514	RASGRF1
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway	1/72	0.8933201792215114	0.9286344469213369	0	0	0.44604017547910413	0.05031788988118056	FLT1
Th1-Cells Activation and Proliferation in Atherosclerosis	1/72	0.8933201792215114	0.9286344469213369	0	0	0.44604017547910413	0.05031788988118056	IL12RB2
Lymphocyte Mediated Myocardial Injury in Myocarditis	1/72	0.8933201792215114	0.9286344469213369	0	0	0.44604017547910413	0.05031788988118056	IL12RB2
Proteins Involved in Chronic Obstructive Pulmonary Disease	3/170	0.8954017501036401	0.9294374891426673	0	0	0.5679364954301922	0.06274720209918418	LGALS3;FGF2;SOD3
Invadopodia Formation in Cancer Cells	1/75	0.9028352245242531	0.9357854152003209	0	0	0.4278910057598582	0.04373697235942712	PDGFA
Endometrioid Ovarian Carcinoma	1/76	0.9058147236547933	0.937505034686448	0	0	0.4221639344262295	0.041760664574829576	LPAR3
Vitiligo	1/78	0.9115028449088762	0.940649738205381	0	0	0.4111560570576964	0.03809795203188335	RASGRF1
Natural Killer Cell Precursor -> Natural Killer Cell Surface Expression Markers	1/78	0.9115028449088762	0.940649738205381	0	0	0.4111560570576964	0.03809795203188335	CD34
mTOR Signaling	1/81	0.9193984004472361	0.9446785301266825	0	0	0.3956762295081967	0.033250942923249656	SLC2A5
Atopic Dermatitis	1/81	0.9193984004472361	0.9446785301266825	0	0	0.3956762295081967	0.033250942923249656	IL12RB2
Clear Cell Ovarian Carcinoma	1/81	0.9193984004472361	0.9446785301266825	0	0	0.3956762295081967	0.033250942923249656	PDGFA
Osteoarthritis	1/82	0.921870732032045	0.9458500285299882	0	0	0.39077109896782025	0.03178933406723539	ADAMTS4
Eosinophil Activation	1/87	0.933141892756723	0.9553772964619553	0	0	0.3679565383149066	0.025461859272011705	MYL9
CC Chemokine Receptor Signaling	1/88	0.9351932690719139	0.9553772964619553	0	0	0.36370830977953644	0.024369208236323225	CCR10
Proteins Involved in HIV Type 1 Infection	1/88	0.9351932690719139	0.9553772964619553	0	0	0.36370830977953644	0.024369208236323225	TAC1
Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling	1/90	0.9391094122318278	0.9557859155998489	0	0	0.355498250138147	0.02233356845888352	RASGRF1
T-Cell Cytotoxic Response against Melanocytes in Vitiligo	1/90	0.9391094122318278	0.9557859155998489	0	0	0.355498250138147	0.02233356845888352	IL12RB2
CD4+T-Cell Response in Celiac Disease	1/91	0.9409779647947809	0.9557859155998489	0	0	0.35153005464480874	0.02138552648923736	IL12RB2
Diffuse Large-B-Cell Lymphoma	1/91	0.9409779647947809	0.9557859155998489	0	0	0.35153005464480874	0.02138552648923736	ALK
Proteins Involved in Rheumatoid Arthritis	1/96	0.9494961868882915	0.9630604181295528	0	0	0.3329421915444349	0.01725431777775219	FGF2
Follicular Lymphoma	1/97	0.9510464543013557	0.9632567511468795	0	0	0.32945696721311474	0.016536225926263966	IL12RB2
T-Cell Acute Lymphoblastic Leukemia	1/103	0.9593996270375659	0.9702117895756011	0	0	0.30998071359691415	0.012847950009813706	RASGRF1
Medulloblastoma	1/104	0.9606463212276725	0.9702117895756011	0	0	0.3069552761419704	0.012323938103610318	S100A4
Apoptosis Evasion in Cancer: Overview	1/106	0.9630262101513722	0.9712338198969805	0	0	0.30107728337236533	0.01134298138452714	HRK
Breast Cancer	1/108	0.9652623886176765	0.9721082211610642	0	0	0.2954190286502222	0.010444631130858934	FLT1
Pancreatic Ductal Carcinoma	1/117	0.97376722073545	0.9792843154704951	0	0	0.2723713962690786	0.0072404480065712444	FLT1
Multiple Myeloma	1/121	0.9768460632680799	0.9803962592499783	0	0	0.2632377049180328	0.0061666591175964045	FGF2
Prostate Cancer	1/123	0.9782473968131513	0.9803962592499783	0	0	0.2588954582101586	0.005693804696661753	RUNX3
Proteins Involved in non-Alcoholic Fatty Liver Disease	2/186	0.9790154194482178	0.9803962592499783	0	0	0.3427750410509031	0.0072695341221731425	LGALS3;AGT
Proteins Involved in Prostate Cancer	1/138	0.9863830901998788	0.9863830901998788	0	0	0.23036974991025488	0.003158477596448985	GJB1
